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ABSTRACT 
 
 
 The physiological role of multidrug resistance protein 4 (Mrp4) in the testes is 
unknown.  It was discovered that Mrp4 is expressed primarily in mouse and human 
Leydig cells; however, there is no current evidence that Mrp4 regulates testosterone 
biosynthesis.  The role of Mrp4 was investigated in Leydig cells where testosterone 
production is regulated by cAMP, an intracellular second messenger formed when the 
luteinizing hormone (LH) receptor (Lhr) is activated.  As Mrp4 regulates cAMP, we 
compared testosterone levels in our Mrp4 WT and KO mice.  Pre-pubertal KO mice had 
significantly reduced testicular testosterone, impaired gametogenesis, and disrupted 
cAMP homeostasis, resulting in decreased expression of genes involved in testosterone 
biosynthesis.  Testosterone production was also impaired in adult KO mice but testicular 
morphology was normal.  In vitro culture of primary KO Leydig cells stimulated with LH 
revealed decreased intracellular cAMP concentrations and attenuated cAMP-response 
element binding protein (CREB) phosphorylation of downstream targets, notably several 
genes directly involved in testosterone biosynthesis.  However, chemical inhibition of 
Mrp4 in WT Leydig cells revealed a substantial elevation in intracellular cAMP 
concentration but paradoxically reduced testosterone production.  The reduced 
testosterone production was related to decreased immunoreactive StAR expression, the 
rate limiting step in testosterone biosynthesis.  Future analysis will focus on the 
mechanism controlling cAMP concentrations under these conditions, with a primary 
focus on cAMP regulation by phosphodiesterases (PDEs). 
 
 Continued assessment of our KO animals revealed pre-pubertal animals had 
reduced systemic testosterone concentrations while adult mice had normal circulating 
levels.  The difference is pre-pubertal KO mice have increased Cyp2b10, a known 
testosterone metabolizing enzyme, expression and catalytic activity due to disrupted 
testicular testosterone production.  Therefore, defective testicular testosterone production 
deregulates hepatic Cyp-mediated testosterone metabolism to disrupt gametogenesis.  
The findings presented here have important implications for understanding the side 
effects of therapeutics that disrupt Mrp4 function and can alter androgen production. 
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CHAPTER 1.    INTRODUCTION 
 
 
ABC Transporters 
 
 By definition, ATP-binding cassette (ABC) transporters are responsible for 
mediating the adenosine triphosphate (ATP) dependent unidirectional exclusion of both 
endogenous and exogenous compounds across membranes [1].  In 1976, the first member 
of the ABC transporter superfamily was identified.  Ling and others described a 170 kD 
membrane glycoprotein overexpressed in colchicine resistant cell lines and termed it P-
gp, a glycoprotein responsible for reducing drug permeability [2].  Over 15 years later, 
two additional ABC transporters were identified.  The first was ABCC1, discovered by 
the laboratories of Cole and Deeley [3] while the second, ABCG2, was identified by three 
independent laboratories almost simultaneously [4-6].  Currently, these three transporters 
are considered to be the major drug transporters that contribute to the multidrug 
resistance phenotype observed in multiple tumors and cell lines [7], a phenomenon 
described as the simultaneous resistance to several structurally unrelated drugs that do not 
have a common mechanism of action [8]. 
 
 While P-GP, ABCC1 and ABCG2 were the first transporters identified, there are 
currently 48 human ABC transporters described, each classified into seven separate 
subfamilies (ABCA-ABCG) based on the sequence and organization of their ATP 
binding domains [9].  As ABC transporters are either localized to the plasma membrane 
or to the membranes of intracellular organelles, they function to move compounds from 
the cytoplasm to outside the cell or into an intracellular compartment such as the 
endoplasmic reticulum, mitochondria or peroxisomes [9].  These transporters serve a 
wide variety of cellular roles such as regulating permeability by being expressed in the 
blood-brain barrier, blood cerebrospinal fluid, blood-testes barrier, and the placenta [10].  
ABC transporters play a protective role by their ability to excrete toxins in such organs as 
the liver, kidney and gastrointestinal tract [11].  Additionally, they serve physiological 
roles in cellular lipid transport and maintenance of homeostasis [12].  With their broad 
expression pattern and functional capabilities, ABC transporters serve a wide variety of 
important physiological functions (Table 1-1). 
 
 Structurally, ABC transporters are comprised of two nucleotide binding domains 
(NBDs) and two transmembrane binding domains (TMDs), encoded by a single 
polypeptide [13].  The NBDs contains the ATP binding domains while the substrate 
binding domains are located within the TMDs.  Within the NBDs are the characteristic 
Walker A and Walker B motifs, separated by approximately 90-120 amino acids.  ABC 
proteins also contain an additional element, the signature C motif, located just upstream 
of the Walker B site [13].  The TMDs contain 6-11 membrane spanning ?-helices while 
the NBDs are located in the cytoplasm.  ABC transporters are classified as full 
transporters if they contain two core units in tandem (TMD-NBD-TMD-NBD) that are 
active alone, or they are half transporters when only one core unit is present (TMD-
NBD).  In the case of half transporters, they must form obligate homo- or hetero-dimers 
for activation [14]. 
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Table 1-1. Localization and function of representative ABC transporters. 
 
Transporter Expression Function 
ABCA1 Ubiquitous Cholesterol efflux to HDL [15] 
ABCA6 Ubiquitous Macrophage lipid homeostasis [16] 
ABCA12 Lamellar granules/bodies Lipid metabolism [17] 
ABCB6 Mitochondria Heme transport and biosynthesis [18] 
ABCB9 Testes, brain, spinal cord Peptide transport [19] 
ABCB11 Liver Bile salt transport [20] 
ABCC1 Lung, testes, peripheral blood Organic anion transporter [21] 
ABCC4 Multiple tissues Drug resistance [22, 23] 
ABCC7 Exocrine tissues Chloride ion channel [24] 
ABCC9 Skeletal muscle, heart K(ATP) channel regulation [25] 
ABCD3 Peroxisomes Peroxisome biogenesis [26] 
ABCG2 Liver, intestine, breast Vitamin B2 pump, heme efflux [27, 28] 
ABCG5 Liver, small intestine Sterol transport [29] 
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The Multi-drug Resistance Protein 4 (MRP4) 
 
MRP4 (ABCC4) is a member of the C subfamily of ABC transporters.  The gene 
is located on chromosome 13q32.1, and at 1325 amino acids in length, is the shortest 
member of this family.  It is a full transporter, comprised of two TMD and two NBD 
(Figure 1-1).  The first functional properties of MRP4 were described in 1999 by 
Schuetz, et al using a human T-lymphoid cell line in which MRP4 overexpression was 
directly linked to impaired antiviral efficacy and increased efflux of antiviral nucleoside 
based drugs [30].  In vitro, MRP4 possesses the unique characteristic of being able to 
export a wide range of structurally diverse compounds.  MRP4 has been shown to 
transport endogenous molecules that play key roles in cellular communication and 
signaling, including cyclic nucleotides, eicosanoids, adenosine diphosphate, and 
conjugated steroid hormones [31].  Other physiologically relevant substrates include 
folate, bile acids and glutathione, which are co-transported with bile acids [32-34].  In 
addition to endogenous substrates, MRP4 also transports a broad range of drug substrates 
including antivirals (adefovir [35] and tenofovir [36]), antibiotics (cefalosporins [37]) and 
cytotoxic agents (methotrexate [33], topotecan [38], 6-thioguanine and 6-mercaptopurine 
[39]. 
 
 MRP4 is also unique from other C subfamily members by its ability to have dual 
membrane localization in polarized cell types.  In renal proximal tubule cells, MRP4 is 
localized to the apical side of the membrane [23] whereas it is located in the basolateral 
membrane in prostate tubuloacinar cells [40] and choroid plexus epithelium [38].  
Interestingly, in a colonic epithelial cell line, protein expression was seen in both the 
apical and basolateral membrane, with increased abundance on the apical side [41]. 
 
 
Development of the Mrp4 KO mouse  
 
 While in vitro studies have been crucial for understanding the transport function, 
substrates and membrane localization of MRP4, it was the development of the Mrp4 KO 
mouse model that derived both the physiological and pharmacological roles of this 
transporter.  Engineered by Leggas, et al, the mouse was generated as follows.  The Mrp4 
gene contains 31 exons, with exon 27 targeted for disruption.  This region lies between 
the Walker A and B motifs and is essential for their communication as well as the 
facilitation of ATP hydrolysis.  Disruption of the Mrp4 gene in embryonic stem cells was 
achieved by replacing exon 27 with a neomycin resistance cassette by homologous 
recombination.  Disruption of Mrp4 expression was ensured by the use of an 
oligonucleotide primer containing three in-frame stop codons engineered into exon 27.  
The result was a complete loss of Mrp4 expression and function.  Examination of these 
animals showed breeding of Mrp4 heterozygous mice produced a normal Mendelian 
ratio, indicating Mrp4 was not required for normal development.  Mrp4 KO mice bred 
normally with normal litter size and the expected male-female ratio.  No abnormalities 
were observed in the brain, liver, lung or kidney when examined by microscopic 
histology.  Liver and renal functions were also within the normal limits [38].  As the KO  
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TMD 
NBD 
Figure 1-1. Structure of Mrp4.  Mrp4 exhibits the classical ABC transporter core 
structure with two transmembrane domains (TMD), the site of substrate binding, and two 
nucleotide binding domains (NBD), the site for ATP binding.  Each TMD contains six ?-
helices.  Both the N-terminal and C-terminal regions of the transporter are located in the 
cytoplasm.  Reprinted by permission from Macmillan Publishers Ltd:  Gottesman MM, 
Fojo T and Bates SE.  Nature Reviews Cancer.  2002 Jan;2(1): 48-58. 
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mouse exhibited no overt detrimental effects from the absence of Mrp4, this indicated 
this mouse could be used as a crucial tool in deciphering the physiological role of Mrp4. 
 
 
Understanding the pharmacological role of Mrp4 through the KO mouse model 
 
 Through this mouse model, Mrp4 was shown to play a critical protective role in 
organs including the brain, liver, kidney and bone marrow cells.  While Mrp4 is mainly 
expressed in the luminal membrane of capillary endothelium, it has been detected in both 
the basolateral membrane of choroid plexus as well as in astrocytes [38, 42].  Studies on 
brain penetration revealed brain and cerebrospinal concentrations of topotecan were 
higher in the KO mouse compared to the WT [38].  These animals also exhibited 
increased adefovir concentrations in the brain, indicating Mrp4 is a component of the 
blood-brain barrier that exports nucleoside based analogues [43].  Localized to the apical 
membrane in kidney proximal tubules, Mrp4 is an important transporter for the 
elimination of many substrates.  The KO mouse has shown Mrp4 to be involved in the 
tubular secretion of diuretics, antiviral drugs and cephalosporins [35, 37, 44].  Mrp4 
protects the liver from toxic bile acid accumulation by facilitating their efflux into the 
blood for renal excretion as illustrated by the sensitization of KO mice to cholestatic-
induced liver injury [22].  Expression of Mrp4 in bone marrow cell lineages (e.g. 
monocyte/macrophage and erythroid precursors) demonstrated its protective role against 
thiopurine-induced hematopoietic toxicity as KO mice were susceptible to dose 
dependent toxicity caused by the accumulation of 6-thioguanine nucleotides in these cells 
[45].  These and other studies illustrate the important role the Mrp4 KO mouse has played 
in understanding the critical physiological role of this transporter. 
 
 
The relationship between Mrp4 and cAMP 
 
 One of the most physiologically important substrates transported by Mrp4 is 
cyclic adenosine 3,5-monophosphate (cAMP).  First characterized in 1957 by Sutherland 
and Rall [46], this second messenger is a critical regulator of intracellular signal 
transduction.  It was not until the mid-1990’s, however, that the essential elements of 
cAMP mediated signaling had been detailed.  Upon the formation of the hormone-
receptor complex, there is a conformational change of the G-protein coupled receptor.  
This activates adenylyl cyclase which generates cAMP from ATP.  In turn, cAMP 
activates PKA which elicits a host of metabolic or physiological responses through its 
downstream target phosphorylation [47]. 
 
 Several transporters have been reported to efflux cAMP, but work performed in 
2001 by Chen and colleges showed MRP4 transported cAMP at a higher affinity than 
other previously reported transporters [39].  Cyclic AMP was originally selected as a 
potential MRP4 substrate based on its structural similarity to the antiviral nucleotide 
substrates as well as the similar protein topology to MRP5 which had previously been 
shown to efflux cAMP [48].  Later studies highlighted the biological importance of 
MRP4-mediated cAMP export.  Experiments performed in the gut epithelial cell line 
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HT29-CL19A, which express both MRP4 and cystic fibrosis transmembrane receptor 
(CFTR) on the apical plasma membrane and can transport cAMP across this membrane.  
As CFTR is a channel activated by cAMP, inhibition of MRP4 by MK571 resulted in 
increased intracellular cAMP concentrations and activation of the CFTR channel [41].  
Similarly, inhibition of MRP4 in mouse ventricular monocytes resulted in increased 
cAMP accumulation and stimulated contraction of the ?-1 adrenocepter [49].  These 
studies, along with others, illustrated how impaired MRP4 function regulates cAMP 
concentration and therefore results in alterations of other cellular processes. 
 
 
The relationship between Mrp4 and steroids  
 
 In addition to the other critical endogenous substrates of MRP4 established by 
Chen, et al, this group was also the first to report MRP4’s ability to efflux steroid 
conjugates.  ABCC1, ABCC2 and ABCC3 had been previously established to transport 
E217?G, a steroid derivative [50-52].  Using inside-out membrane vesicles generated 
from MRP4 overexpressing insect cells, it was shown E217?G was transported by MRP4 
with affinity similar to ABCC3 [52].  Further evidence of MRP4’s ability to transport 
steroids came in 2003 when it was shown dehydroepiandrosterone sulfate (DHEAS) 
could be effluxed by MRP4 in an inside-out membrane vesicle system [53].  As DHEAS 
is a major circulating steroid in humans, mainly produced in the adrenal glands, and was 
the highest affinity substrate for MRP4 at that time, these results suggested a major 
function of MRP4 may be the transport of DHEAS itself or of other structurally related 
steroids. 
 
 While initial data did suggest MRP4 may be responsible for effluxing steroid and 
steroid-like compounds, a later study revealed neither the primary male sex hormone 
testosterone nor dihydrotestosterone (DHT), the more potent reduced form of 
testosterone, were transported by MRP4 [54].  Interestingly, two separate reports showed 
MRP4 expression is androgen responsive as its expression is increased upon treatment 
with DHT [54, 55] but is decreased upon androgen withdrawal [54].  While not a direct 
transporter of testosterone or DHT, these data suggest that MRP4, as an androgen 
regulated gene, may be important in the progression of androgen dependent cancers, such 
as prostate cancer where MRP4 is highly expressed [54]. 
 
 
Leydig Cells and Testosterone Regulation 
 
 
Testes and its primary cell types 
 
 The testes are the male sex organ responsible for two basic functions:  sperm 
production and testosterone biosynthesis.  The adult testes contain several major cell 
types.  First, spermatogonial stem cells, residing at the luminal side of the basal 
membrane of the seminiferous tubules, undergo several successive mitotic divisions, 
developing into mature sperm cells.  Sertoli cells, the second essential testicular cell type, 
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act as a supporting structure for developing sperm as they are attached to the basal lamina 
of the seminiferous tubules.  Their direct contact with proliferating and differentiating 
germ cells within the tubules are essential for providing both physical and nutritional 
support for spermatogenesis [56].  Finally, Leydig cells lie in the interstitial space 
between the seminiferous tubules and function to both synthesize and secrete testosterone 
[57] (Figure 1-2).  Comprising only 5% of mature testes volume, there are approximately 
500 million Leydig cells present in the adult human male [58].  As adult Leydig cells are 
post-mitotic, this population arises during puberty and persists for the whole adult life 
[59].  A normal adult human male produces approximately 7 mg testosterone daily but 
also produces other androgens such as androstenedione and dehydroepiandrosterone 
(DHEA) [60].  However, due to strain differences in mice, absolute testosterone 
concentrations cannot be established for this species. 
 
 
Testosterone biosynthesis in the Leydig cells 
 
 Testosterone biosynthesis is stimulated when luteinizing hormone (LH) is 
released form the anterior pituitary gland and acts on its receptor located on the plasma 
membrane of Leydig cells.  This initiates a cascade of events including the activation of 
adenylyl cyclase, increased intracellular cAMP formation which then activates protein 
kinase A (PKA).  PKA phosphorylates the steroidogenic acute regulatory protein (StAR), 
a mitochondrial associated protein, which translocates cytoplasmic cholesterol from the 
outer mitochondrial membrane to the inner mitochondrial membrane.  This is considered 
to be the rate-limiting step in testosterone biosynthesis.  In addition to StAR, cholesterol 
is also brought into the mitochondria by a second importer, peripheral benzodiazepine 
receptor (PBR).  Once inside the mitochondria, cholesterol is converted to pregnenolone 
by the enzyme cholesterol side chain cleavage (Cyp11?1) where it is then translocated 
into the smooth endoplasmic reticulum.  It is then converted to testosterone via a series of 
reactions involving 3-beta-hydroxysteroid dehydrogenase (3?HSD), steroid 17-alpha-
monooxygenase (Cyp17?? and 17-beta-hydroxysteroid dehydrogenase (17?HSD) [61-
63] (Figure 1-3).  After synthesis is complete, testosterone exits the Leydig cells be a 
process generally accepted as passive diffusion [64] where upon release, it enters the 
circulation where it inhibits the release of LH from the anterior pituitary [65], ultimately 
creating a pulsatile cycle of testosterone formation and secretion.  After the onset of 
puberty, over 95% of circulating testosterone is derived from the testes with the 
remainder arising from testosterone precursors DHEA and androstenedione, both 
originating from the adrenal gland [66]. 
 
 
Testosterone maintains testicular homeostasis 
 
 In the male, testosterone plays the lead role in both morphological development as 
well as reproductive function.  The absolute requirement for testosterone is supported by 
experiments such as testosterone suppression, hormone withdrawal, and animal KO 
models.  Utilizing a testosterone deficiency model in rats, administration of a chronic,  
 8 
  
Figure 1-2. Histology of the testes.  Testes histology as visualized by H&E staining 
at 40X magnification.  Labeled are the Leydig cells which lie in the interstitium 
between the seminiferous tubules.  Inside the seminiferous tubules, both the Sertoli 
cells as well as developing sperm cells (spermatogonium, spermatocytes and 
spermatids) are visible. Reprinted with permission from DeltaBase histology atlas.  
http://www.deltagen.com/target/histologyatlas/atlas_files/male_rep/testis_40X.jpg.  
Accessed October 16, 2012. 
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Figure 1-3. Testosterone biosynthesis pathway.  Illustration of the molecular 
events involved in testosterone production by Leydig cells. Luteinizing hormone binds 
to receptors on the Leydig cell plasma membrane, thereby initiating a cascade of events 
that includes increased intracellular cAMP formation, translocation of cholesterol into 
the mitochondria (with the involvement of steroidogenic acute regulatory protein and 
peripheral benzodiazepine receptor), association of cholesterol with Cyp11?1, 
production of pregnenolone from cholesterol in the mitochondria, translocation of 
pregnenolone from the mitochondria to the smooth endoplasmic reticulum, and 
conversion of pregnenolone to testosterone via a series of reactions in the smooth 
endoplasmic reticulum.  All biosynthesis enzymes are colored red.   
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low dose testosterone/estradiol implant resulted in the suppression of LH to undetectable 
levels with testicular testosterone concentration reported as less than 3% of controls.  As 
a result, production of elongated spermatids, a late stage germ cell, ceased.   
Administration of high dose testosterone produced an increase in testosterone 
concentration as well as normalized spermatid maturation [67].  Suppression of 
gonadotropin-releasing hormone, the upstream hormone responsible for the release of LH 
from the anterior pituitary, resulted in an LH deficiency and decreased intratesticular 
testosterone levels, thereby creating a severe spermatogenic impairment [68].  Reduction 
in testicular and prostatic weights was also observed, highlighting the importance of 
testosterone in the maintenance of androgen dependent organs. 
 
 Hormone withdrawal experiments also emphasize the critical role of testosterone 
in supporting spermatogenesis.  Removal of androgens from adult rats by 
hypophysectomy resulted in an acute, stage specific regression of the seminiferous tubule 
epithelium, leading to a reduced number of early stage spermatocytes attached to the 
basal lamina.  Additionally, elongated spermatids exhibited an abnormal morphology 
with atypical head shapes and abnormalities in the flagellum [69].  Following 
hypophysectomy and elimination of all residual testosterone by flutamide, 
spermatogenesis was observed to rarely proceed beyond meiosis.  A minimal amount of 
round spermatids could be observed and elongated spermatids were virtually non-existent 
[70]. 
 
 The utilization of animal KO models also enforced testosterone as an important 
regulator of spermatogenesis and reproductive function.  Similar to observations made 
with gonadotropin suppression, the loss of the gonadotropin-releasing hormone gene in a 
mouse model produced a congenital functional gonadotropin deficiency, resulting in 
deficient LH and testosterone concentrations secondary to the absence of gonadotropin-
releasing hormone [71].  Studies in hypogonadal mice lacking gonadotropin releasing 
hormone show a decrease in testosterone synthesis genes Cyp11?1 and Cyp17?1 early as 
postnatal day 5 [72], contributing to decreased testosterone and spermatogenic arrest.  
Subdermal implants of either testosterone or DHT into gonadotropin-releasing hormone 
deficient mice induced complete spermatogenesis and a dose-dependent increase in all 
germ cell types induced by both testosterone and DHT [73].  Targeted disruption of the 
Lhr gene in mice produced infertile males with reduced testicular weight, disorganized 
seminiferous tubule structure and arrested spermatogenesis.  Few Leydig cells were 
detected, consistent with decreased testosterone concentration.  Testosterone replacement 
therapy in Lhr KO mice improved spermatogenic capacity and although sperm counts 
remained low, sperm motility was achieved [74]. 
 
 
Testosterone is a critical regulator of multiple physiological processes 
 
 In addition to sustaining testicular homeostasis, testosterone is vital to multiple 
physiological processes.  Testosterone and DHT both act on the androgen receptor (AR) 
which, when bound to an androgen, interacts with androgen response elements in the 
DNA and induces subsequent effects on transcriptional activity.  As multiple cell types 
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express AR, testosterone can influence a vast array of actions.  One major target of 
testosterone is the skeletal system, with much focus on bone growth and health.  
Androgen receptors are present in all layers of the human growth plate, and multiple 
studies have suggested testosterone, via the AR, influences longitudinal bone growth in 
early puberty [75].  In a rodent model, testosterone injected directly into the growth plate 
increased its width by approximately 15% over controls [76].  Testosterone, both directly 
and through aromatization to estrogen, influence bone marrow stromal cells, pre-
adipocytes, endothelial cells within bone marrow and osteoblastic progenitors which 
expresses AR and estrogen receptors [77].  In particular, DHT directly stimulates the 
proliferation of osteoblast precursors and the differentiation of osteoblasts via Wnt 
signaling [78]. 
 
 The utilization of testosterone therapies draws attention to its ability to promote 
retention and gain of muscle mass, particularly in symptomatic hypogonadal men or in 
the elderly male population.  Short term testosterone therapy administered to elderly men 
possessing serum testosterone concentration at the lower limit of the normal range 
provided benefits such as increases in serum testosterone and lean body mass as well as 
decreased urinary hydroxyproline excretion, an indication of declining bone resorption 
[79].  Studies examining elderly, hypogonadal men undergoing testosterone therapy have 
reported increased muscle volume as well as increased leg and arm muscle strength [80], 
decreased body fat coupled with increased lean body mass [81] and elevated muscle 
protein synthesis [82]. 
 
 Multiple epidemiological studies have stressed the importance of testosterone in 
the metabolic syndrome, a term encompassing such physiological features as abdominal 
obesity, insulin resistance, hypertension and dyslipidemia [83].  Testosterone 
administration in non-obese men showed correlation between increased serum 
testosterone and decreased visceral fat accumulation [84] while androgen therapy in older 
men also resulted in reduced abdominal and peripheral adipose tissue [85].  The Telecom 
Study, a large epidemiological study of healthy males, observed a potential association of 
testosterone and cardiovascular risk factors.  Serum triglycerides, total cholesterol, low-
density lipoprotein cholesterol, and plasma insulin were higher while values of serum 
high-density lipoprotein cholesterol were lower in men with lower serum testosterone 
levels [86].  An inverse association between low endogenous testosterone levels and 
increased systolic blood pressure was reported in a study analyzing normal males [87] 
while middle-aged men with abdominal obesity, upon administration of a regimen of 
testosterone therapy, exhibited decreased diastolic blood pressure as well as depressed 
plasma triglycerides, cholesterol and fasting blood glucose concentrations [88]. 
 
 While these types of studies do not mechanistically determine how testosterone 
affects these processes, they do provide solid evidence of its role in the regulation of 
certain human physiological conditions.  As maintaining proper testosterone 
concentration is a crucial, it also becomes necessary to understand the factors which 
contribute to and affect normal testosterone biosynthesis itself. 
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Regulation of Testosterone Biosynthesis 
 
 
Functional StAR and Pbr are necessary for testosterone synthesis 
 
 The entry of cholesterol, the precursor of testosterone, into the mitochondria is 
widely considered to be the rate-limiting step of testosterone biosynthesis.  As a result, 
proper functioning of StAR and Pbr, the two cholesterol import genes, becomes a critical 
regulatory point in testosterone biosynthesis.  Regulation of StAR has been demonstrated 
to involve multiple transcription factors and signaling pathways.  StAR was originally 
identified as a phosphoprotein with phosphorylation sites for both PKA and protein 
kinase C.  Comparison of StAR protein sequences from multiple species indicated two 
consensus PKA motifs at serine 57 and serine 195 [89] while studies performed in 
glomerula cells demonstrated protein kinase C can also phosphorylate StAR [90].  
Phosphorylation of StAR is crucial for proper steroidogenesis.  The functional 
significance of this was exhibited in a series of experiments in which serine to alanine 
mutants of the StAR protein were examined in Cos-1 cells engineered to produce 
steroids.  Mutation at the conserved PKA target site at serine 57 had no effect on 
synthesis; however, a mutation at serine 195 resulted in an approximate 50% reduction in 
steroid concentration.  Furthermore, mutation of this residue to an aspartic acid slightly 
increased StAR activity, as measured by pregnenolone synthesis.  These results suggested 
that phosphorylation of StAR at serine 195 increases its biological activity which 
partially accounts for the immediate effects of cAMP on steroid production [89].  Several 
theories exist as to how phosphorylation by PKA affects the mechanistic function of 
StAR.  A report by Baker, et al showed cholesterol binding to StAR was not affected by a 
mutation at serine 195 but concluded the action of PKA enhanced the capacity of StAR to 
function at the mitochondria [91].  These same studies showed a reduced ability to induce 
steroidogenesis when recombinant human StAR bearing the same mutation was 
introduced in vitro into isolated mitochondria.  Another hypothesis contends PKA 
phosphorylation of StAR increases the time it spends at the outer mitochondrial 
membrane, suggesting that its activity is proportional to the amount of time it resides at 
the membrane [92].  The absence of StAR as examined by a KO mouse model revealed 
animals that possessed a residual capacity for steroidogenesis with severely depressed 
serum testosterone levels.  Additionally, an accumulation of lipid droplets was observed 
in both the gonads and adrenal glands of StAR KO animals [44].  As the mutation at 
serine 195 is one of the many point mutations in human StAR that reportedly gives rise to 
congenital lipoid adrenal hyperplasia [93], proper function of StAR is required for normal 
steroidogenesis and maintenance of steroid-related functions. 
 
 As exhibited with StAR, it is crucial for Pbr, the second cholesterol importer, to 
be fully functional.  Whereas StAR acts to bring cholesterol into the outer mitochondrial 
membrane, Pbr has been shown to translocate cholesterol from the outer mitochondrial 
membrane to the inner mitochondrial membrane [94].  The critical role of Pbr was 
demonstrated in studies where knocking down Pbr expression led to an attenuation of 
human chorionic gonadotropin (hCG)-induced cholesterol into the mitochondria as well 
as impaired steroid synthesis.  This occurred even in the presence of hormone induced 
 13 
StAR activity [95].  The disruption of Pbr in a steroid producing R2C rat Leydig cell line 
resulted in a 10% production of steroids when compared to the normal cells.  Addition of 
a CYP11?1 substrate, 22R-hydroxycholesterol, to the Pbr negative cells restored steroid 
production, indicating the cholesterol transport mechanism was impaired due to the 
absence of Pbr [96].  The efforts to generate a Pbr KO mouse resulted in embryonic 
lethality, suggesting Pbr is involved in the basic functions necessary for embryonic 
development [97].  A conditional Pbr KO animal has not been reported so in the in vivo 
contribution of Pbr has yet to be fully elucidated. 
 
 A 2001 report by West and colleagues proposed a physical interaction occurred 
between StAR and Pbr as measured by fluorescence energy transfer [98].  Two 
subsequent experiments suggested Pbr may actually regulate the function of StAR by 
controlling its import into the mitochondria.  First, in Leydig cells where Pbr levels were 
knocked down, low levels of mature StAR protein formed in response to hormone 
induction.  This correlated with the absence of steroid formation [95].  In the same report, 
it was demonstrated that a Pbr antagonist given in the presence of hCG produced an 
inhibition of steroid synthesis in Leydig cells, corresponding with a decrease in mature 
StAR protein formation.  These results raised the hypothesis that the import and 
processing of StAR into the mitochondria may be dependent on Pbr.  This was tested by 
the addition of in vitro transcribed/translated mature StAR into mitochondria of MA-10 
Leydig cells increased steroid formation, but cells with knocked down Pbr failed to form 
steroids even in the presence of StAR.  Reincorporation of Pbr rescued the ability of the 
mitochondria to respond to StAR, suggesting a functional interaction between StAR and 
Pbr at the outer mitochondrial membrane where Pbr controls StAR import and processing 
into mitochondria as well as StAR mediated cholesterol transport [95].  These data 
demonstrate the importance of both StAR and Pbr as critical regulators of steroidogenesis 
and also highlight their dependence on each of for maximal functional capacity. 
 
 
Cyclic AMP regulates multiple processes in the testosterone synthesis pathway 
 
 The second messenger, cAMP, is responsible for the regulation of a host of 
biological processes, often through the activation of PKA.  Careful scrutiny of the 
testosterone biosynthesis pathway reveals multiple steps are under cAMP regulation.  The 
initial step, activation of Lhr, is regulated by cAMP concentration.  Experiments 
performed by Kishi, et al in LH/hCG receptor (alternate name for Lhr) expressing rat 
granulosa cells indicated basal cAMP activity is required for LH/hCG receptor 
expression.  However, when cells were incubated for longer periods of time with hCG, 
the LH/hCG receptor exhibited decreased mRNA expression.  The authors concluded that 
a labile destabilizing factor induced by cAMP may be responsible for the degradation of 
the LH/hCG receptor mRNA [99].  Studies performed several years earlier in MA-10 
cells showed that when treated with hCG or a cAMP derivative, 8-bromo-cAMP, there 
was a reduction in LH/hCG receptor mRNA expression and, additionally, a decrease in 
receptor number on the membranes as a result of receptor mediated endocytosis [100].  
The reduction in LH/hCG receptor mRNA expression was shown to be a result of a 
decreased rate of transcription when these cells were treated with 8-bromo-cAMP [101].  
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The decrease in receptor expression as a result of increased cAMP is a regulatory 
checkpoint to prevent continuous receptor activation and therefore constant stimulation of 
steroid synthesis. 
 
 Cholesterol import genes are also subject to cAMP regulation.  Cyclic AMP 
activates transcription of cAMP-responsive genes through the interaction of the cAMP 
response element (CRE) binding protein (CREB) with a conserved CRE sequence in the 
promoter regions of these genes [102].  Instead of the typical CRE binding motif, StAR 
contains a cAMP responsive region which is mediated by protein kinases [103].  The 
classical cAMP-PKA signaling cascade has been shown to upregulate the transcription of 
the StAR gene [104, 105].  Studies performed by Stocco and colleagues reported 
transfection of MA-10 and Cos-1 cells with a vector containing wild-type CREB resulted 
in increased steroidogenesis, StAR promoter activity and StAR mRNA expression.  The 
increase in activity was not observed when a dominant negative or non-phosphorylatable 
CREB was transfected into cells [106].  It was concluded that while the StAR promoter 
did not contain a consensus CRE site, CREB could play a role in StAR promoter 
transactivation, potentially by binding to an alternate non-consensus site or by binding to 
the promoter in an indirect manner.  Cyclic AMP has been shown to regulate StAR 
protein expression through PKA activity.  Mouse adrenocortical Y1 cells and derived 
PKA mutant adrenal tumor Kin-8 cells were treated with 8-bromo-cAMP, with StAR 
mRNA detectable in both cell lines, but Kin-8 cells had only a 50% expression level 
compared to that of the Y1 cells.  Increased StAR protein was observed in the normal Y1 
cells while it was undetectable in the mutant PKA Kin-8 line [107].  Analysis of the 
second cholesterol importer, Pbr, has not revealed it to be a target of CREB activation but 
a study has suggested there is a cAMP-inducible element regulating its structure and 
function.  Using MA-10 cells as a model system, Boujrad and others showed treatment 
with hCG resulted in increased cAMP concentration as well as elevated steroid formation 
as a result of hCG binding to benzodiazepine.  This was completely reversed upon the 
addition of a selective PKA inhibitor, indicating Pbr is potentially regulated by cAMP 
[108]. 
 
 Phosphorylation of CREB by PKA is also a critical cAMP-regulated component 
of the testosterone biosynthesis pathway.  Three genes directly involved in the synthesis 
of testosterone, Cyp17?, Cyp11? and 3?HSD, all contain CREB binding sites within 
their promoters [109].  This effect can be observed by studies which demonstrated that, in 
the absence of cAMP, de novo synthesis of Cyp17? was halted in cultured Leydig cells, 
and the major steroid product produced was progesterone.  Upon chronic cAMP 
treatment, the major product was shifted back to testosterone, indicating the requirement 
of cAMP for Cyp17? function and, thereby, its importance in sustaining testosterone 
synthesis [110].  The duration of phosphorylation at serine 133, the CREB 
phosphorylation site, can determine the efficacy of downstream target gene expression.  
Experimental analysis has shown sustained phosphorylation promotes increased CREB 
target gene induction while a rapid phosphorylation/dephosphorylation cyclic did not 
promote gene induction [111]. 
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Testosterone metabolism 
 
 Steroid hormones are maintained by a dynamic balance between steroidogenesis 
and steroid inactivation (Figure 1-4).  This ensures correct physiological function is 
continuously occurring.  While the liver is the most important organ involved in steroid 
hormone metabolism, other organs including the skin [112], lung, spleen and intestine 
[113] have been implicated in the breakdown of steroids.  Steroid metabolism does not 
always reduce the biological activities of hormones but instead can render them inactive 
through metabolic conversion.  Elimination of these lipophilic molecules from the cell 
occurs through an array of enzymatic reactions followed by their transport across the cell 
membrane.  In general, the major metabolic pathways of steroids in humans are the 
following:  oxidation, primarily through hydroxylation, by cytochrome P450 (CYP450) 
enzymes [114], conjugation with glucuronide [115] or sulfate [116] and O-methylation 
by catechol O-methyltransferase [117].  Steroid hydroxylation produces products with 
higher polarity so the metabolites are more easily conjugated and excreted [118].  As 
with most steroid metabolism, the liver is responsible for the majority of steroid 
metabolism resulting from CYP450 hydroxylation [114].  In humans, there are 18 
families and 43 subfamilies of CYP450 genes [119].  Steroids are metabolized by several 
members of the CYP450 families including CYP1A, CYP1B, CYP2B, CYP2C, 
CYP3A,CYP7A and CYP7B [113] however CYP2B and CYP3A are largely responsible 
for testosterone metabolism.  Hydroxylation of testosterone can occur at, but is not 
limited to, the following positions:  2?, 6?, 6?, 7?,?16?, 16?, and 17??????????The 
CYP3A family isoforms account for up to 60% of the total CYPs present in the human 
liver with CYP3A4 considered to be the most versatile  enzyme involved in the 
metabolism of endogenous steroid hormones [121].  Studies have demonstrated CYP3A4 
is responsible for testosterone 11?-, 15?-, and 16?-hydroxylation [122].  The second 
important CYP family involved in testosterone metabolism, CYP2, accounts for 
approximately 30% of human hepatic CYPs [123].  It has been shown that human 
CYP2B6 is the only CYP involved in 16?- [124] and 16?-hydroxylation [125].  
CYP2C19 is also capable of metabolizing testosterone, forming androstenedione as a 
major metabolite [126].  CYP19A1, also known as aromatase, can transform testosterone 
into estradiol in regions such as the ovary, placenta and brain [127]. 
 
 As it has been shown CYPs metabolize steroids, there are also reports that 
steroids are able to regulate CYP expression, namely mouse Cyp2b10 (CYP2B6 in 
humans) and testosterone.  Work performed in mice by Honkakoski, et al demonstrated 
that castrated males presented with elevated Cyp2b10 mRNA and protein expression in 
comparison to intact animals.  This was accompanied by an increase in Cyp2b10 catalytic 
activity.  This was alleviated upon testosterone administration to the castrated males 
[128].  These data were one of the first to suggest a negative correlation between 
Cyp2b10 expression and testosterone concentration.  Later evidence further confirmed 
this result.  As hepatic Cyp2b10 had been identified as a direct target of the nuclear 
orphan receptor CAR [129], experiments were performed in which HepG2 cells were  
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Figure 1-4. The balance between steroid biosynthesis and inactivation.  Steroid 
hormones are maintained through a dynamic balance between steroidogenesis and 
steroid inactivation to ensure their proper physiological functions, which are largely 
mediated through the activation of ligand-specific steroid hormone receptors.  
Reprinted from Chemico-Biological Interactions, 147(3), You L, Steroid hormone 
biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes, 
233-246, copyright 2004, with permission from Elsevier. 
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transfected with NR1, a CAR-responsive enhancer found in both mouse and human 
Cyp2b genes.  Treatment with either testosterone, androstenedione, progesterone or 
androstenediol all resulted in a dose-dependent decrease in NR1 activity, indicating 
repression occurred through CAR activation.  This was reversed by the addition of 
estrogens [130].  These collective results indicate Cyp2b10 and testosterone exist in a 
crucially balanced relationship, as the expression of one component tightly regulates the 
expression of the other. 
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CHAPTER 2.    THE ABSENCE OF MRP4 IN LEYDIG CELLS RESULTS IN 
REDUCED INTRATESTICULAR TESTOSTERONE CONCENTRATION* 
 
 
Introduction 
 
 Expression of multiple ABC transporters present in the testes has been well 
established in the literature.  Pgp, Abcg2, Abcc1, Abcb9, Abcb6, Abcb8 and Abca5 have 
all been identified in various testicular cells types.  Abca5 localization is reported in 
Leydig cells [131]; however, its exact role has yet to be elucidated.  Similarly, the precise 
contribution of Abca9, Abcb6 and Abcb8 has not been determined with respect to 
testicular function.  Interestingly, the transcripts of each of these transporters have been 
identified in distinct cell types.  Abcb9 was identified in Sertoli cells while Abcb6 was 
expressed in the germline, with positive expression observed in spermatocytes and early 
spermatids.  Abcb8 transcript was detected in Sertoli cells and peritubular cells as well as 
spermatogonia and spermatocytes [132].  Even without full functional characterization, it 
is immediately detectable that ABC transporters have no discernible distribution pattern 
in the testes. 
 
 Other ABC transporters have been more extensively characterized with respect to 
functional contribution as well as cellular localization.  Immunohistochemical staining 
has revealed that Pgp, Abcg2 and Abcc1, like the aforementioned transporters, have no 
distinct expression pattern in the testes.  Pgp is found in myoid cells, Leydig cells and 
endothelial cells; Abcg2 has been identified in myoid and endothelial cells while Abcc1 
is localized to both Sertoli cells, and to a lesser extent, Leydig cells [133].  Additionally, 
Abcg2 was recently discovered to be localized to spermatogonial stem cells, providing 
the first evidence of this transporter in this compartment [134].  As these transporters are 
located in different cell layers of the normal testes, it was suggested they provided 
optimal protection of spermatogenesis by exporting potentially harmful substrates.  While 
there are multiple studies confirming the protective role of these transporters in the testes, 
that data will not be discussed as our main focus concerns the relatively undefined role of 
transporters in regulating testicular steroid biosynthesis. 
 
 A 2010 report by Sivils, et al was the first to describe how the absence of an Mrp 
transporter, namely Abcc1, resulted in reduced serum and testicular testosterone levels in 
the absence of drug challenge [135].  This work provided the first evidence that a 
transporter may influence the steroid biosynthetic process although the mechanism was 
not elucidated. 
 
 Prior to the work presented here, it was well established that Mrp4 is expressed in 
both human and murine testes [136, 137], although its cellular localization and precise 
contribution had yet to be established.  As it might be hypothesized that Mrp4 plays a  
 
* Modified with permission.  Morgan JA., et al.  Deregulated hepatic metabolism 
exacerbates impaired testosterone production in Mrp4-deficient mice.  J Biol Chem, 
2012.  287(18): p. 14456-66 [138]. 
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protective role in the testes, as seen with Pgp, Abcg2, and Abcc1, no data existed to 
support this.  There was also no evidence linking Mrp4 as a regulator of testosterone 
biosynthesis although it was reported that neither testosterone nor DHT were substrates 
for Mrp4 [54].  Through the use of the Mrp4 KO mouse, my contribution was to provide 
a more in-depth understanding of the importance Mrp4 provides in testes, beginning with 
its cellular localization and examination of testicular function. 
 
 
Experimental Procedure  
 
 
Animals 
 
 The generation of the Mrp4 KO mouse had been described previously [38].  All 
mice used during the duration of these studies were maintained on a mixed C57BL6/129 
background and generated by intercrossing littermates.  Mice were housed and fed under 
identical conditions until experiments were performed. 
 
 
Immunohistochemistry (IHC) 
 
 Whole testes were harvested from Mrp4 WT and KO mice and immediately 
formalin fixed.  Samples were submitted to the St. Jude Veterinary Pathology Core where 
they were paraffin embedded and sectioned into 4 micron sections.  Following standard 
slide mounting procedure, the testes sections were stained with M4I-10, a monoclonal 
Mrp4 antibody (a gift from Dr. George Scheffer).  Testes were stained with hematoxylin 
& eosin (H&E) for analysis of overall testicular morphology.  Additionally, they were 
stained with an antibody for the cell proliferation marker, Ki67, and for terminal 
deoxynucleotidyl tranferase dUTP nick end labeling (TUNEL), an antibody detecting cell 
apoptosis.  All staining was performed using the LabVision 720 autostainer (Thermo 
Shandon). 
 
 
Immunoblotting 
 
 Testes from pre-pubertal and adult WT and KO mice were ultrasonically 
disrupted in a mixture of M-Per reagent (Thermo Scientific) plus a protease inhibitor 
cocktail (Roche Diagnostics).  Protein concentration was determined by the Bradford 
assay method [139].  Proteins were suspended in a mixture of 2X Laemmeli sample 
buffer containing 5% ?-mercaptoethanol but were not denatured by boiling.  Proteins 
were then size fractionated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis.  All gels were hand cast.  The running gel was composed of 29.2% 
acrylamide-0.8% Bis (National Diagnostics, Inc.), 1.5 M Tris-0.4% SDS (Sigma 
Aldrich), double deionized water, 10% ammonium persulfate (Biorad) and Temed 
(Biorad).  The stacking gel consisted of 29.2% acrylamide-0.8% Bis (National 
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Diagnostics, Inc.), 0.5 M Tris-0.4% SDS (Sigma Aldrich), double deionized water, 10% 
ammonium sulfate (Biorad) and Temed (Biorad). 
 
 Following size fractionation, the proteins were transferred onto a nitrocellulose 
membrane (Midwest Scientific) overnight in a solution of 10% 1X Tris-glycine 
(Amresco), 20% methanol, and 70% double deionized water.  Following transfer, blots 
were blocked in a 10% milk/phosphate buffered saline (PBS)-Tween solution for 60 
minutes then washed 3X for 5 minutes with 1X PBS-Tween.  Primary antibodies were 
made in a 10% milk/PBS-Tween solution, and blots were rocked at room temperature for 
150 minutes then washed 5X for 5 minutes each in 1X PBS-Tween.  Secondary antibody 
were made in the same solution and incubated for 60 minutes at room temperature, 
followed by the same washing step as just described.  Blots were then exposed to 
enhanced chemiluminescence reagent (GE Healthcare) for one minute and protein was 
visually detected by exposure to film (Denville Scientific). 
 
 
Testicular testosterone measurement 
 
 Testicular testosterone concentration was measured from WT and KO mice by 
harvesting testes, homogenizing in 1X PBS with a glass Dounce homogenizer, and 
centrifuging at 5900 x g for 5 minutes at 4oC.  The supernatant was then combined with 1 
ml diethyl ether, vortexed, and the organic phase was collected and dried down under a 
stream of N2 at room temperature.  The dried fraction was reconstituted in 0.2 ml 1X 
PBS.  Testosterone concentration was then measured by a 125I-labeled radioimmunoassay 
(RIA) (MP Biomedicals) according to the manufacturer’s instructions.  Concentration of 
testicular testosterone was expressed as ng/mg of testes weight. 
 
 
Immunohistochemical counting 
 
 All IHC quantitation was performed on a minimum of three mice per age and 
genotype group.  Counts were taken on five random fields per slide at 40 X magnification 
on a Nikon Eclipse Ti microscope.  For TUNEL and Ki67 staining, the cell was 
considered positive if greater than 50% of the individual cell was stained. 
 
 
Results 
 
 
Mrp4 is localized to Leydig cells  
 
 As expected, immunoblot analysis revealed Mrp4 protein expression in whole 
testes extract from Mrp4 WT testes.  Mrp4 was also detected in the isolated Leydig cell 
fraction from WT testes.  No protein expression was observed in Leydig cells or whole 
testes from KO animals.  Analysis of Abcc1 (Mrp1) showed decreased expression in 
Leydig cells as compared to whole testes, where Abcc1 (Mrp1) is highly expressed in the   
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Sertoli cells that reside in the seminiferous tubules [140] (Figure 2-1A).  In accordance 
with the immunoblot analysis, IHC confirmed Mrp4 localization in the Leydig cells of 
both mouse (Figure 2-1B) and human (Figure 2-1C).  Mrp4 was undetectable inside the 
seminiferous tubules, indicating it is not expressed in Sertoli or germ cells.  These results 
provide the first evidence of Leydig cell localization of Mrp4. 
 
 
The absence of Mrp4 in Leydig cells does not affect general reproductive 
parameters 
 
 Phenotypically, Mrp4 WT and KO animals are indistinguishable from one 
another.  Both genotypes of mice are reproductively normal, producing comparable litter 
sizes (Figure 2-2A) and ratios of offspring that conform to classical Mendelian 
inheritance (not shown).  In addition, testes weight was comparable between the 
genotypes, although KO mice did exhibit a slight increase (Figure 2-2B).  As general 
reproductive parameters were not altered between WT and KO mice, the loss of Mrp4 
was then examined with respect to total Leydig cell number.  Immunohistochemical 
analysis of testes of mice ranging in age from 3 weeks to 6 weeks revealed similar 
number of absolute Leydig cells, with the exception of 3 week old KO mice.  These mice 
exhibited an approximate 30% reduction in Leydig cell number (Figure 2-2C).  Leydig 
cell proliferation analysis of the same samples demonstrated WT and KO mice had 
proportional numbers of proliferating cells (Figure 2-2D).  However, 6 week old Mrp4 
KO mice did possess fewer proliferating cells than did their WT counterparts.  Overall, 
our results revealed the absence of Mrp4 in Leydig cells does not generally affect their 
total cell number or proliferation status. 
 
 
Pre-pubertal Mrp4 KO mice are deficient in testicular testosterone 
 
 It had been previously observed that the loss of an Mrp transporter expressed in 
the Leydig cells resulted in testosterone deficiency [135].  In addition to Leydig cells, this 
transporter was simultaneously expressed in Sertoli cells, so the transporter’s exact role 
in testosterone reduction could not be discerned with respect to its Leydig cell expression.  
For these studies, our initial analysis revealed Mrp4 expression to be solely localized to 
the Leydig cells, making it possible to reveal the role Mrp4 plays in these cells and how 
its loss affects the testes as a whole. 
 
 Initial experiments focused on pre-pubertal mice.  Prior work in our lab revealed 
Mrp4 protein expression increases in the testes as mice mature from pre-pubertal animals 
to adulthood (Figure 2-3), so it was of interest to examine our animals at two different 
stages of sexual maturity.  Pre-pubertal mice were designated as exactly 21 days of age as 
genes responsible for steroid biosynthesis can show upregulation as early as 25 days after 
birth [141, 142], indicating the onset of puberty.  Examination of testicular testosterone 
concentration revealed a drastic decrease in levels of the Mrp4 KO mouse, only 20% of 
the concentration observed in WT animals (Figure 2-4). 
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Figure 2-1. Mrp4 is expressed in Leydig cells.  (A)  Immunoblot analysis of Mrp4 
and Mrp1 protein in Leydig cell and testes.  Immunohistochemical analysis (400x 
magnification) shows Mrp4 is visible in both (B) mouse and (C) human Leydig cells as
indicated by the red staining (see arrows). 
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Figure 2-2. Mrp4 KO mice display normal reproductive parameters.  (A)  Average 
number of pups per litter in WT (n = 51 litters) and KO (n = 53 litters) matings.
(B)  Mean testes weight of Mrp4 WT (n= 37) and KO (n= 37) mice.  (C)  Mean testicular 
Leydig cell counts (n = 3 mice per age and genotype).  (D)  Mean testicular Leydig cell 
proliferation (Ki67+ cells per total Leydig cell number) (n = 3 mice per age and 
genotype).  All error bars = SE. 
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Figure 2-3. Mrp4 protein expression increases with age.  Immunoblot analysis 
of Mrp4 expression in testes of WT and KO mice (left).  Actin was used as a loading 
control (top).  Expression ratios plotted from absolute band intensity (bottom) using 
ImageJ software. 
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Figure 2-4. Pre-pubertal Mrp4 KO mice are deficient in testicular testosterone. 
Testosterone concentration in Mrp4 WT (n = 9) and KO (n = 4) testes as measured by 
125I-labeled radioimmunoassay. 
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To assess how the absence of Mrp4 affected the testes, several parameters were 
analyzed.  As testosterone is required for gamete maturation [143], analysis was 
conducted on whole testes in order to determine germ cell maturation status.  Primary  
spermatids were detected in 50% of the seminiferous tubules of WT mice compared to 
only 25% in KO mice (Figure 2-5A), indicating WT testes possess a more mature germ 
cell population.  In conjunction, germ cell proliferation was investigated in the same 
sample set.  Using Ki67, a marker for cell proliferation, a 33% reduction in proliferating 
germ cells was observed in the KO seminiferous tubules (Figure 2-5B).  This result 
suggested defective germ cell mitosis occurred in the absence of Mrp4.  To further 
confirm this result, expression analysis of testicular RNA showed genes important in 
germ cell mitosis, including Ccnb1, Cdc25c, and E2f, were slightly reduced in KO testes.  
pRm1, a gene important in gamete chromatin assembly, was drastically reduced in these 
animals (data not shown) confirming germ cell maturation is defective in KO mice.  In 
addition, as germ cell maturation is controlled by both proliferation and apoptosis [144], 
the number of apoptotic cells was assessed by TUNEL staining of the whole testes.  
Results showed a greater than 30% increase in TUNEL positive cells in tubules of KO 
mice as compared to their WT counterparts (Figure 2-5C). 
 
 
Conclusions 
 
 We show that Mrp4 is localized specifically to the Leydig cells of the testes, but 
its absence does not affect general reproductive parameters including litter size or 
Mendelian inheritance ratio.  Testes weight is unaltered between the genotypes, and total 
Leydig cell number is comparable between WT and KO as mice approach adulthood with 
the exception of the 3 week age.  Similarly, Leydig cell proliferation was comparable as 
mice aged. 
 
 Examination of pre-pubertal Mrp4 KO mouse testes revealed decreased 
intratesticular testosterone concentration in comparison to WT animals.  This was 
accompanied by impaired spermatogenesis and reduced germ cell proliferation.  
Additionally, increased germ cell apoptosis was observed in these same KO animals.  
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Figure 2-5. Pre-pubertal Mrp4 KO mice exhibit impaired testicular morphology.  
(A)  Testicular morphology of WT and KO mice (H&E stain, 40x magnification).  
Arrows indicate elongated spermatids in WT mice but immature spermatogonia are only 
detected in KO mice.  Enlarged insets show these cells in the seminiferous tubules lumen.  
Graph below quantitates percentage of seminiferous tubules containing elongated 
spermatids as examined in a high power field.  (B)  Cell proliferation in testes utilizing 
Ki67 staining.  Graph below is a quantification of Ki67+ cells expressed as mean number 
per high power field (40x magnification).  (C)  Mean number of apoptotic germ cells per 
high power field (40x magnification) by TUNEL assay.  All error bars = SE. 
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CHAPTER 3.    TESTICULAR TESOSTERONE BIOSYNTHESIS IS 
IMPAIRED IN MRP4 KO MICE* 
 
 
Introduction 
 
 Testosterone biosynthesis is dependent on both acute and chronic stimulation of 
Leydig cells by the pituitary hormone LH which binds to specific high affinity receptors 
on the cell surface.  This results in the activation of adenylate cyclase followed by 
increased cAMP, mediating both acute and chronic effects of LH.  The rapid, acute 
response involves the transport of cholesterol, the precursor of testosterone, to the inner 
mitochondrial membrane by way of cholesterol transport proteins StAR and Pbr.  
Chronic stimulation of Leydig cells by LH is required for optimal expression of enzymes 
and proteins necessary for testosterone biosynthesis.  The beginning steps of the 
conversion of cholesterol to the ultimate product of testosterone begin with cholesterol 
metabolized to pregnenolone through the actions of the enzyme Cyp11??.  Pregnenolone 
then exits the mitochondria and is transferred to the smooth endoplasmic reticulum where 
addition reactions involving 3?HSD1, Cyp17?1, and 17?HSD1 result in the final product 
of testosterone [61-63] 
 
 Interference with many of the steps involved in testosterone biosynthesis can 
result in decreased, or in some instances, complete ablation of testosterone production.  
Studies utilizing Lhr KO mice demonstrated that adult testes were devoid of mature 
Leydig cells and exhibited thin seminiferous tubules with arrested spermatogenesis.  Full 
steroidogenesis was not achievable without gonadotropin stimulation [145, 146].  
Impeded StAR function and expression also negatively impacts steroid biosynthesis.  
Mutation of the conserved PKA target site serine 195 resulted in an approximate 50% 
reduction in steroid production in Cos-1 cells engineered to generate steroids [89].  
Decrease in StAR mRNA and protein expression by environmental factors such as 
exposure to phthalate esters and heavy metals also result in decreased steroidogenesis 
[147].  Similarly, loss of the second cholesterol transport protein, Pbr, produces impaired 
steroid biosynthesis.  Targeted disruption of Pbr in a R2C Leydig cell line resulted in 
steroid production in only 10% of the cells when compared to WT [97].  These collective 
results demonstrate the importance of an unimpaired biosynthesis pathway is necessary 
for maximal steroid production. 
 
 In addition to the above mentioned mechanisms, these and other genes directly 
involved in steroid biosynthesis are regulated by cAMP.  Anakwe and Payne exhibited 
that, in the absence of cAMP. de novo synthesis of Cyp17? ceases in cultured Leydig 
cells, with the major steroid product becoming progesterone.  Chronic cAMP treatment 
then shifted the major product back to testosterone, indicating the requirement of cAMP 
for Cyp17? function and synthesis [110].  Additionally, Cyp17?, Cyp11? and 3?HSD all  
_______________________________________________________________________ 
*Modified with permission.  Morgan JA., et al.  Deregulated hepatic metabolism 
exacerbates impaired testosterone production in Mrp4-deficient mice.  J Biol Chem, 
2012.  287(18): p. 14456-66 [138]. 
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contain promoters with CREB binding sites [109], a transcription factor whose activation 
results in increased transcription of these downstream target genes.  As CREB activation 
is a cAMP dependent process, it is required for maximal expression of these biosynthesis 
genes. 
 
 Inhibition of cAMP by a phosphodiesterases (PDE) expressed in Leydig cells also 
highlighted the importance of cAMP as a modulator of testosterone biosynthesis.  
Through the use of isolated Leydig cells in a PDE8A KO mouse model, an increase was 
observed in LH stimulated testosterone production, likely due to increased cAMP 
concentration.  PDE8A KO Leydig cells treated with 3-isobutyl-1-methylxanthine 
(IBMX), a pan PDE inhibitor, exhibited an even more robust increase in testosterone 
concentration when stimulated with LH [148].  These results indicate inhibition of cAMP 
dependent PDEs is a potent way to modulate LH signaling and steroid biosynthesis while 
also emphasizing cAMP concentration is critical for testosterone production. 
 
 Based on the results obtained in Chapter 2, we sought to determine the 
mechanism by which testicular testosterone concentration was reduced in Mrp4 KO mice.  
As the testosterone biosynthesis pathway can be regulated at multiple levels, it was 
imperative to examine each individual component to determine the exact defect that 
resulted in decreased testosterone. 
 
 
Experimental Procedure  
 
 
LH measurement 
 
 Whole blood was collected by retro-orbital eye bleed from WT and KO mice, 
incubated at 4oC for 2 hours, then centrifuged at 5900 x g for 5 minutes in order to 
separate the serum from the remaining clotted blood.  LH concentrations were assayed 
from the serum by the Center for Research in Reproduction Ligand Assay and Analysis 
Core at the University of Virginia School of Medicine (Charlottesville, VA).  LH was 
measured by an immunoradiometric sandwich assay and the final concentration was 
expressed in ng/ml. 
 
 
Immunoblot analysis 
 
 Immunoblot analysis was performed in whole testes samples as described in 
Chapter 2 with the exception that all protein samples examined were denatured by boiling 
for 5 minutes at 95oC in a 2X Laemmeli sample buffer containing 5% ?-mercaptoethanol.  
The assayed proteins were Lhr (AbD Serotec), StAR (Santa Cruz Biotechnology, Inc.), 
Pbr (Everest Biotech), Cyp11?1 (Chemicon International), 3?HSD1 (Abcam), Hmgcs1 
(Abcam), Dhcr7 (Santa Cruz Biotechnology, Inc.), VDAC (Mitosciences), CREB and 
phospho-CREB Ser133 (Cell Signaling Technology).  Relative protein quantities were 
determined by densitometry using ImageJ software. 
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Leydig cell testosterone measurement 
 
 Leydig cells were isolated as previously described from three mice of each 
genotype.  Samples were pooled for analysis, and testosterone was measured directly 
using the RIA as described previously.  Testosterone concentration is expressed as ng/ug 
protein. 
 
 
cAMP determination  
 
 Basal cAMP measurements were taken from freshly isolated Leydig cells which 
were immediately lysed in 0.1 M hydrochloric acid.  Intracellular cAMP content was 
assayed using the acetylated version of a cAMP complete enzyme-linked immunosorbent 
assay (Enzo Life Sciences ) according to the manufacturer’s instructions.  Results are 
expressed as pmol per 106 cells. 
 
 Under stimulated conditions, isolated Leydig cells were plated at a density of 106 
cells per well in a six well plate using DMEM/F12 media (Invitrogen).  Cells were treated 
with a 10 mIU/ml LH (Sigma), a physiological concentration, and 0.1 mM IBMX 
(Sigma), a PDE inhibitor.  Following a three hour incubation at 37oC, cells were collected 
using a cell lifter, centrifuged at 5900 x g for 5 minutes at 4oC, and cAMP concentration 
was assayed as described above. 
 
 
CREB phosphorylation 
 
 Leydig cells were isolated from WT and KO mice, plated at a density of 106 cells 
in a six well plate in DMEM/F12 media (Invitrogen).  Cells were then stimulated with 10 
mIU/ml LH for the indicated time points.  Cells were harvested, protein was measured by 
Bradford assay, and the samples were subjected to immunoblot analysis probing for 
phospho-CREB133 and total CREB (Cell Signaling Technology).  The loading control 
was an unknown protein that cross-reacted with the antibody but remained constant 
among the samples.  Densitometry was assessed using ImageJ software. 
 
 
RNA isolation 
 
 Leydig cells were isolated from three mice of both WT and KO testes and 
homogenized in 1 ml Trizol Reagent (Invitrogen) using a hand held homogenizer.  
Samples were incubated at room temperature for 5 minutes to allow for complete 
dissociation of nucleoprotein complexes.  Following incubation, 0.2 ml chloroform was 
added, samples were vigorously shaken for 15 seconds and incubated at room 
temperature for 3 minutes.  Samples were then centrifuged at 12000 x g for 15 minutes at 
4oC.  After centrifugation, the aqueous phase was collected, mixed with 0.5 ml isopropyl 
alcohol and incubated at room temperature for 10 minutes.  Samples were centrifuged at 
12000 x g for 10 minutes at 4oC.  The supernatant was removed, the pellet was washed 
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with 1 ml 75% ethanol, vortexed, then centrifuged at 7500 x g for 5 minutes at 4oC.  The 
ethanol wash was removed, the pellet was air dried then dissolved using RNAse free 
water by incubating for 10 minutes for at 60oC. 
 
 
Real-time PCR 
 
 Real-time polymerase chain reaction (PCR) was performed on isolated Leydig 
cells using 20 ng of diluted cDNA with SYBR Green (Invitrogen) and 300 nM gene 
specific primers using the ABI 7900HT sequence detection system (ABI).  Primer 
sequences were designed using Primer Express (ABI).  The PCR protocol was as follows:  
10 minute denaturation step, 40 cycles of two-step PCR (15 seconds at 95oC and 60 
seconds at 60oC) followed by a dissociation step (15 seconds at 95oC, 15 seconds at 60oC 
and 15 seconds at 95oC).  The fold difference in expression was normalized to the 
housekeeping gene Gapdh and was calculated using the ??Ct method.  The following 
primer sequences were utilized:  Lhr (sense, 5’-GCGCGCCGGATGGT-3’; antisense, 5’-
AAAGCTTGTGATGGGATTACTTTGA-3’), StAR (sense, 5’-
CGGGTGGATGGGTCAAGTT-3’; antisense, 5’-
GGACAGCTCCTGGTCACTATAGAGT-3’), Pbr (sense, 5’-
CTGGACACTGGCTCCCATCT-3’; antisense, 5’-
CCAGCTCTTTCCAGACTATGTAGGA), Cyp11?1 (sense, 5’-GGCCGGCGGATTGC-
3’; antisense, 5’-CATCACGGAGATTTTGAACTTCAA-3’), 3?HSD1 (sense, 5’-
CCCAGGCAGACCATCCTAGA-3’; antisense, 5’-
GAACACAGGCCTCCAATAGGTT-3’), and Cyp17?1 (sense, 5’-
CCAGAGAAGTGCTCGTGAAGAA-3’; antisense, 5’-CCTTTTCCTTGGTCCGACAA-
3’). 
 
 
Microarray expression analysis 
 
 RNA was purified from Leydig cells of pre-pubertal and adult WT and KO mice.  
Analysis used nine pre-pubertal and five adult mice per genotype.  RNA from each age 
and genotype group was combined prior to analysis.  After RNA quality was confirmed 
(Agilent Bioanalyzer 2100), RNA was processed using the Affymetrix one-cycle target 
labeling protocol and hybridized overnight to the Affymetrix Mouse 430 vs 2 array.  
Array signals were summarized using the MAS 5 algorithm and log2 transformed prior to 
analysis.   
 
 Microarray analysis was performed by using the Spotfire Decision Site version 
9.1 (TIBCO).  For genes interrogated by multiple probe sets, a single expression value 
was calculated using the maximum signal reported across redundant probe sets.  Genes 
associated with steroid metabolism were identified by annotations curated from Entrez 
Gene, Gene Ontology and GeneGo Metacore terms [149].  For cAMP target genes, the 
PKA, CREB and cAMP pathways were curated from known direct and indirect target 
genes. 
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Results 
 
 
Expression of Lhr, but not LH concentration, is decreased in Mrp4 KO mice  
 
 Both LH concentration and the upregulation of Lhr in response to stimulation are 
critical initial steps in the regulation of testosterone synthesis.  Because of this, our 
examination began with these critical factors.  In adult mice, serum LH concentration was 
not significantly different between the genotypes (Figure 3-1A).  However, immunoblot 
analysis of total Lhr protein revealed an approximate reduction of 70% in KO mice 
(Figure 3-1B).  While the comparable circulating LH levels were an unexpected result as 
we would have predicted elevated concentrations in the KO due to decreased 
testosterone, decreased Lhr protein expression was the first indication that a defect 
existed in the biosynthesis pathway itself. 
 
 Lhr signaling is essential for steroidogenesis as well as cholesterol homeostasis 
[150].  Two genes important in de novo cholesterol biosynthesis were examined in 
isolated Leydig cells by real-time PCR.  Both Hmgcs1 and Dhcr7 mRNA levels were 
decreased in KO mice as compared to WT animals (Figure 3-2A).  Measurement of total 
serum cholesterol showed no difference in levels between the genotypes (Figure 3-2B), 
indicating the defect in LH-regulated cholesterol biosynthesis appears to be Leydig cell 
specific. 
 
 
Cyclic AMP concentration is drastically diminished in Mrp4 KO Leydig cells  
 
 The concentration of cAMP within the Leydig cell is crucial for the regulation of 
testosterone biosynthesis.  As our results showed upstream components of the 
testosterone biosynthesis pathway were downregulated, it was essential to measure 
cAMP in our mice to determine how its potential alteration may contribute to decreased 
testicular testosterone in Mrp4 KO mice.  Prior to analysis of cAMP levels, measurement 
of testosterone concentration in isolated Leydig cells revealed decreased levels in Mrp4 
KO cells (Figure 3-3A), analogous to the reduction observed in whole testes sample.  
These results aid in confirming the deficiency in testosterone originates in Leydig cells 
and is not dependent on other factors acting on these cells. 
 
 Analysis of basal cAMP concentration in Leydig cells showed an inherent defect 
in cAMP concentration (Figure 3-3B).  In Leydig cells stimulated with a physiological 
concentration of LH, cAMP concentration remained lower in Mrp4 KO than in WT cells 
(Figure 3-3C).  Although cAMP levels were elevated in both genotypes in response to 
LH stimulation, KO Leydig cells exhibited a modest two fold increase in cAMP 
concentration while WT cells produced a five-fold elevation over basal levels. 
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Figure 3-1. Luteinizing hormone receptor expression, but not LH concentration, 
is altered in Mrp4 KO mice.  (A)  Serum LH concentration measured by 
radioimmunoassay (n = 3 mice/genotype).  (B)  Lhr protein in Leydig cells as assessed by 
immunoblot analysis.  A nonspecific band was used as a loading control.  Graph below 
expresses ratios of band intensity.  All error bars = SE. 
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Figure 3-2. Cholesterol biosynthesis genes are reduced in Mrp4 KO mice but 
serum cholesterol concentrations are unchanged between genotypes.                    
(A)  Cholesterol gene expression in KO Leydig cells by real-time PCR, presented as the 
mean ratio of expression in WT cells.  (B)  Serum cholesterol concentration measured 
by enzymatic assay (WT, n = 10, KO, n = 8).  All error bars = SE. 
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Figure 3-3. Cyclic AMP concentration is decreased in Mrp4 KO Leydig cells.  
(A)  Testosterone concentration in adult Leydig cells as measured by radioimmunoassay 
(n = 3 mice/genotype).  (B)  cAMP concentration in Leydig cells under basal conditions 
as evaluated by enzyme immunoassay (n = 3 mice/genotype).  (C)  cAMP concentration 
in Leydig cells stimulated with 10mIU LH (n = 3 mice/genotype).  All error bars = SE. 
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CREB activation, a cAMP dependent phenomenon, and downstream target gene 
expression are reduced in Mrp4 KO Leydig cells  
 
 To further validate the decrease seen in cAMP concentration in Mrp4 KO Leydig 
cells, both CREB phosphorylation status and its downstream target gene expression were 
examined.  CREB mediated transcription requires phosphorylation at a particular residue, 
Ser133.  Activated by a variety of protein kinases, this site is phosphorylated by cAMP 
dependent PKA [151] thereby promoting gene transcription of a wide array of targets.  
Initial experiments focused on the phosphorylation status of CREB in WT and KO 
Leydig cells.  Stimulation with a physiological concentration of LH showed a rapid 
increase in the amount of phospho-CREB while decreasing total CREB protein in WT 
samples.  In stark contrast, KO Leydig cells exhibited slow CREB phosphorylation under 
LH stimulation and show minimal change in the phospho-CREB/CREB ratio versus the 
unstimulated state (Figure 3-4A).  In the absence of stimulation, CREB protein 
expression was similar in WT and KO cells. 
 
 Microarray expression analysis was then utilized to curate target genes common 
to PKA, CREB and cAMP activation pathways to determine if gene expression 
downstream of CREB was altered in KO Leydig cells.  A total of 38 genes were 
identified (Table 3-1) and all showed strongly reduced expression in pre-pubertal and 
adult KO Leydig cells (Figure 3-4B).  These findings corroborated the results, 
implicating the lack of Mrp4 in Leydig cells impairs LH mediated cAMP formation, 
thereby disrupting CREB mediated transcription. 
 
 
Genes directly involved in testosterone biosynthesis are downregulated in Mrp4 KO 
Leydig cells 
 
 Initial analysis of a broad spectrum of genes related to steroid biosynthesis 
showed striking similarities in the expression of affected genes in pre-pubertal and adult 
KO Leydig cells (Figure 3-5).  As our data revealed both cAMP concentration and 
CREB phosphorylation to be impaired in KO Leydig cells, coupled with the fact that 
genes involved directly in testosterone biosynthesis contain promoters with CREB 
binding sites, expression of these specific genes were investigated.  Real-time PCR 
analysis of Leydig cell mRNA indicated a reduction in all testosterone biosynthesis genes 
evaluated (Figure 3-6A).  The most substantial decrease occurred with StAR expression 
where a reduction of over 60% was observed.  In contrast, minimal reduction of Pbr, the 
second cholesterol importer, was seen in KO Leydig cells.  Decreased mRNA expression 
of Cyp11?1, Cyp17?1, and 3?HSD1 was also confirmed in this sample set.  Protein 
expression of these genes revealed a similar pattern of reduced expression in the KO 
(Figure 3-6B) with the exception of Pbr.  Of the mitochondrial proteins examined, StAR, 
Pbr, and VDAC, only StAR was reduced.  The decreased proteins levels of Cyp11?1 and 
3?HSD1 were also consistent with the mRNA data, and these overall results reinforce the 
findings of reduced testicular testosterone in Mrp4 KO mice. 
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Figure 3-4. CREB phosphorylation and cAMP regulated genes are 
downregulated in Mrp4 KO Leydig cells.  (A)  Immunoblot analysis of CREB and 
phosphor-CREB (Ser133) at the indicated time points and treatment conditions.  The 
loading control was an unknown protein cross-reactive with the antibody that remained 
constant among the samples.  The graph at right shows ratio of phosphor-CREB to 
CREB.  (B)  Selection of cAMP-regulated genes for query.  The heat map represents 
the gene expression in WT and KO Leydig cells. 
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Table 3-1. cAMP-, PKA-, and CREB-regulated genes in Leydig cells. 
Gene Symbol Gene Name 
GLG1 golgi apparatus protein 1 
BMP6 bone morphogenetic protein 6 
CLCN3 chloride channel 3 
NRP1 neuropilin 1 
PPP3CB protein phosphatase 3, catalytic subunit, beta isoform 
CTNNB1 catenin (cadherin associated protein), beta 1 
YWHAB tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, beta polypeptide 
GNA13 guanine nucleotide binding protein, alpha 13 
HDGF hepatoma-derived growth factor 
ADCY9 adenylate cyclase 9 
MYLK myosin, light polypeptide kinase 
PPP1R8 protein phosphatase 1, regulatory (inhibitory) subunit 8 
KCTD12 potassium channel tetramerisation domain containing 12 
MAP2K5 mitogen-activated protein kinase 5 
AKAP11 A kinase anchor protein 11 
AKAP9 A kinase anchor protein 9 
CREBBP CREB binding protein 
YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, zeta polypeptide 
CLCN6 chloride channel 6 
ITPR1 inositol 1,4,5-triphosphate receptor 1 
PYGB brain glycogen phosphorylase 
SMAD4 MAD homolog 4 (Drosophila) 
CHUK conserved helix-loop-helix ubiquitous kinase 
YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, gamma polypeptide 
H1F0 H1 histone family, member 0 
CLCN1 chloride channel 2 
CREB1 cAMP response element binding protein 1 
KCTD3 potassium channel tetramerization domain-containing protein 3 
PIK3R4 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 4, 
p150 
PPP1R12A protein phosphatase 1, regulatory subunit 12A 
GRB2 growth factor receptor bound protein 2 
ATF1 activating transcription factor 1 
PPKAR1A protein kinase, cAMP dependent regulatory, type I, alpha 
PLCG1 phospholipase C, gamma-1 
PPKD3 protein kinase D3 
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Table 3-1.       cont. 
 
Gene Symbol Gene Name 
ADD3 adducin 3 (gamma) 
POLR2B polymerase (RNA) II (DNA directed) polypeptide B 
PDE3B phosphodiesterase 3B, cGMP inhibited 
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Figure 3-5. Steroid biosynthesis and related genes have a distinct expression 
pattern in Mrp4 WT and KO mice.  The expression of steroid biosynthetic genes in 
pre-pubertal and adult Mrp4 WT and KO mice as examined by microarray analysis.  
Hierarchical cluster was performed on ‘steroid’ genes curated from EntrezGene, Gene 
Ontology and Metacore. 
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Figure 3-6. Genes involved directly in testosterone biosynthesis are 
downregulated in Mrp4 KO Leydig cells.  (A)  Real-time PCR analysis of 
testosterone biosynthesis gene expression in Mrp4 KO Leydig cells (normalized to 
GAPDH expression).  (B)  Immunoblot analysis of testosterone biosynthesis gene 
expression.  Vdac was used as a loading control.  All error bars = SE. 
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Acute Mrp4 inhibition results in elevated intracellular cAMP concentrations  
 
 The aforementioned results exhibited the importance of Mrp4 in regulating 
normal testosterone biosynthesis; however, the reduced intracellular cAMP concentration 
observed in the KO mice was still perplexing as cAMP is a substrate for Mrp4 [39].  As 
Leydig cells in culture produce testosterone in a dose dependent manner upon LH 
stimulation (Figure 3-7A) and also express testosterone biosynthesis proteins including  
StAR and Cyp11?1 (Figure 3-7B), we utilized this system to examine the factors 
resulting in decreased Mrp4 KO cAMP concentration. 
 Treatment of WT Leydig cells with 10 mIU LH resulted in increased testosterone 
in the media in contrast to the unstimulated group.  Inhibition of Mrp4 with 10uM 
MK571 produced a sizeable decrease in testosterone concentration, similar to the 
unstimulated cells (Figure 3-8A).  Simultaneous measurement of intracellular cAMP 
revealed concentrations were elevated greater than five-fold when Mrp4 was inhibited 
(Figure 3-8B).  Protein expression levels examined under these same conditions showed 
both Lhr and StAR were downregulated when Mrp4 was inhibited while Cyp11?1 
expression was not affected (Figure 3-8C).  Analysis of other ABC transporters present 
in the testes (Abcc1 and Abcg2) exhibited no change in expression levels when Mrp4 KO 
Leydig cells are stimulated with LH (Figure 3-9). 
 
 
Conclusions 
 
 Neither circulating LH nor cholesterol levels were altered between the Mrp4 WT 
and KO mice; however, Leydig cell Lhr protein expression was downregulated in the KO 
animal while key cholesterol biosynthesis genes were also decreased.  Cyclic AMP 
concentration was also decreased in KO Leydig cells in both the basal state as well as in 
LH stimulated cells.  CREB phosphorylation, a cAMP dependent event, was attenuated in 
KO Leydig cells stimulated with LH and accordingly, downstream target gene expression 
was decreased.  In conjunction, mRNA and protein expression were decreased for several 
key testosterone biosynthesis genes including Cyp11?1, Cyp17?1 and most crucial, 
cholesterol importer, StAR.   
 
 In contrast with cAMP concentrations observed in the KO animal, acute inhibition 
of WT Leydig cells in culture showed increased intracellular concentrations when 
stimulated with LH.  Both Lhr and StAR protein expression was decreased upon Mrp4 
inhibition while Cyp11?1 protein was unchanged.  No change in expression was 
observed in other testes transporters when WT Leydig cells were LH stimulated. 
  
 43 
  A 
B 
Figure 3-7. Cultured Leydig cells exhibit properties observed in vivo.              
(A)  Testosterone concentration in WT Leydig cells upon stimulation with various 
concentrations of LH as measured by radioimmunoassay.  (B)  Immunoblot analysis of 
testosterone biosynthesis genes in culture under indicated treatment conditions.  
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Figure 3-8. Acute inhibition of Mrp4 results in increased intracellular cAMP 
concentration but downregulated Lhr and StAR protein expression.                        
(A)  Testosterone concentration in Mrp4 WT Leydig cells under the indicated treatment 
conditions as measured by radioimmunoassay.  (B)  cAMP concentration in Mrp4 WT 
Leydig cells as assessed by enzyme immunoassay.  (C)  Protein expression as determined 
by immunoblot analysis in WT Leydig cells.
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Figure 3-9. Alternate ABC transporters are not upregulated upon LH 
stimulation.  Protein expression of Abcc1 and Abcg2 in Mrp4 WT and KO cultured 
Leydig cells under the indicated conditions. 
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CHAPTER 4.    ADULT MRP4 KO MICE MAINTAIN A TESTICULAR 
TESTOSTERONE DEFICIENCY WHILE POSSESSING NORMAL 
TESTES MORPHOLOGY* 
 
 
Introduction 
 
 Adequate testosterone concentration is required for the maintenance of normal 
spermatogenesis although the absolute amount required is still unknown.  Studies have 
exhibited experimental testosterone reduction can lead to an abolition of sperm 
production when testicular testosterone concentration is less than 20% of the controls 
[152].  Hormonal removal has been shown to induce germ cell apoptosis [153] while the 
presence of testosterone maintains spermatogenic homeostasis by inhibiting death signals 
for germ cells [154].  Additionally, gonadotropin withdrawal in rodents has shown to 
reduce the number of germ cells progressing through the multiple stages of 
spermatogenesis [155]. 
 
 Our data regarding pre-pubertal Mrp4 KO animals revealed reduced 
intratesticular testosterone accompanied by impaired spermatogenesis, germ cell 
proliferation and increased apoptosis.  As KO mice are reproductively normal (discussed 
in chapter 2), my goal was to characterize the adult mice testes in the same manner as 
with the pre-pubertal animals in order to determine if all observed deficiencies were still 
present. 
 
 
Experimental Procedure  
 
 
Immunohistochemistry 
 
 Whole testes and prostate were harvested from Mrp4 WT and KO mice and 
immediately formalin fixed.  Samples were submitted to the St. Jude Veterinary 
Pathology Core where they were paraffin embedded and sectioned into 4 micron sections.  
Following standard slide mounting procedure, the testes sections were stained with H&E 
for analysis of overall testicular morphology.  Additionally, testes were stained with an 
antibody for the cell proliferation marker, Ki67, and for TUNEL, an antibody detecting 
cell apoptosis.  All staining was performed using the LabVision 720 autostainer (Thermo 
Shandon). 
 
 
 
 
________________________________________________________________________ 
* Modified with permission.  Morgan JA., et al.  Deregulated hepatic metabolism 
exacerbates impaired testosterone production in Mrp4-deficient mice.  J Biol Chem, 
2012.  287(18): p. 14456-66 [138]. 
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Testicular testosterone measurement 
 
 Testicular testosterone concentration was measured from WT and KO mice by 
harvesting testes, homogenizing in 1X PBS with a glass Dounce homogenizer, and 
centrifuging at 5900 x g for 5 minutes at 4oC.  The supernatant was then combined with 
1ml diethyl ether, vortexed, and the organic phase was collected and dried down under a 
stream of N2 at room temperature.  The dried fraction was reconstituted in 0.2ml 1X PBS.  
Testosterone concentration was then measured by an 125I-labeled RIA (MP Biomedicals) 
according to the manufacturer’s instructions.  Concentration of testicular testosterone was 
expressed as ng/mg of testes weight. 
 
 
Immunohistochemical counting 
 
 All IHC quantitation was performed on a minimum of three mice per age and 
genotype group.  Counts were taken on five random fields per slide at 40X magnification 
on a Nikon Eclipse Ti microscope.  For TUNEL and Ki67 staining, the cell was 
considered positive if greater than 50% of the individual cell was stained. 
 
 
Results 
 
 As a result of the findings from our pre-pubertal animals, it was imperative that 
the same set of experiments were performed on the adult mice to determine if the 
testicular testosterone deficiency persevered into adulthood.  Most laboratory mouse 
strains have a reported pubertal onset of 34-38 days after birth (online ref).  To ensure 
that sexually mature animals were being examined, mice greater than 8 weeks of age 
were selected for analysis. 
 
 Adult Mrp4 KO mice had a six-fold reduction in testicular testosterone 
concentration in comparison to WT mice (Figure 4-1).  Despite reduced testosterone, 
histological examination revealed readily detectable mature sperm cells in the 
seminiferous tubule lumen (Figure 4-2A).  In conjunction, germ cell proliferation was 
equivalent among the genotypes as determined by Ki67 positive staining (Figure 4-2B).  
Germ cell apoptosis was similar between the WT and KO animals (Figure 4-2C).  These 
data indicate that, despite decreased intratesticular testosterone levels, Mrp4 KO mice 
have morphologically normal testes. 
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Figure 4-1. Testicular testosterone is decreased in adult Mrp4 KO mice.  
Testosterone concentration in adult Mrp4 WT (n = 7) and KO (n = 4) mice as measured 
by radioimmunoassay.  Error bars = SE. 
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A B 
C 
Figure 4-2. Testicular deficiencies are absent in the adult Mrp4 KO mouse.          
(A)  Testicular morphology as examined by H&E staining (20X magnification).  Arrows 
indicate mature sperm tail in the seminiferous tubule lumen.  (B)  Immunohistochemical 
analysis of cell proliferation with Ki67 antibody.  Graph below quantitates Ki67+ cells.  
(C)  Quantification of apoptotic cells by TUNEL positive staining.  All error bars = SE. 
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Conclusions 
 
 Adult Mrp4 KO mice showed greatly reduced testicular testosterone when 
compared to WT animals but possessed a mature sperm cell population with normal germ 
cell proliferation and minimal apoptosis.   
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CHAPTER 5.    DECREASED SERUM TESTOSTERONE IN PRE-PUBERTAL 
MRP4 KO MICE RESULTS FROM INCREASED METABOLISM* 
 
 
Introduction 
 
 The liver is the most important organ of steroid hormone metabolism.  Biological 
activities of hormones are not always reduced by steroid metabolism but can be rendered 
inactive by metabolic conversion.  Steroid molecules are eliminated from cells through an 
array of enzymatic reactions followed by transport across the cell membrane.  In the liver, 
several categories of reactions occur that alter steroid hormone activity: hydroxylation, 
conjugation, and oxido-reduction.  The major metabolic pathway of steroids is through 
hydroxylation by cytochrome p450 enzymes [114] which are expressed in almost every 
tissue with the exception of skeletal muscle and red blood cells [156].  Several 
constitutively expressed Cyp enzymes are involved in testosterone inactivation in a 
regioselective and stereospecific manner [157] as they catalyze nicotinamide adenine 
dinucleotide phosphate (NADPH) dependent monooxygenation of their hydrophobic 
substrates [158].  The enzymatic reactions of testosterone hydroxylation include, but are 
not limited to, hydroxylation at the following positions:  2?, 6?, 6?, 7?,?16?, 16?, and 
17? [120].  6?-hydroxylation is the major route of NADPH dependent oxidative 
metabolism, accounting for over 75% of the total hydroxylated metabolites generated by 
human liver microsomes when testosterone, androstenedione or progesterone are used as 
substrates [159]. 
 
 Testosterone is primarily metabolized by members of the Cyp2 and Cyp3 
families.  Although human CYP3A4 (Cyp3a11 in mice) is generally regarded as the most 
versatile enzyme involved in endogenous steroid metabolism [121], mouse Cyp2b10 
(CYP2B6 in humans) plays an important role in testosterone metabolism.  In vitro and in 
vivo studies have shown Cyp2b10 and testosterone exist in a negative relationship [128, 
130] as testosterone can suppress Cyp2b10 expression and vice versa. 
 
 Our preliminary data reveals serum testosterone concentration is decreased in pre-
pubertal Mrp4 KO mice, but levels are restored to a more normal concentration once 
these mice reach adulthood.  My goal was to examine the potential mechanisms by which 
testosterone concentration was reduced in these animals, mainly focusing on Cyp2b10 
expression and activity. 
 
 
 
 
 
 
________________________________________________________________________ 
* Modified with permission.  Morgan JA., et al.  Deregulated hepatic metabolism 
exacerbates impaired testosterone production in Mrp4-deficient mice.  J Biol Chem, 
2012.  287(18): p. 14456-66 [138]. 
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Experimental Procedure  
 
 
Serum testosterone measurement 
 
 Serum testosterone was measured by collecting whole blood from Mrp4 WT and 
KO mice and incubating at 4oC for 90 minutes in a microtainer collection tube (Becton 
Dickinson).  Samples were spun at 1200 x g for 90 seconds, serum was collected, and 
testosterone was measured by 125I-labeled RIA (MP Biomedicals) per the manufacturer’s 
instructions.  Serum testosterone concentration is expressed as ng/ml. 
 
 
Androstenedione measurement 
 
 Whole blood was collected by retro-orbital eye bleed from WT and KO mice, 
incubated at 4oC for 2 hours, then centrifuged at 5900 x g for 5 minutes in order to 
separate the serum from the remaining clotted blood.  Androstenedione concentrations 
were assayed from the serum by the Center for Research in Reproduction Ligand Assay 
and Analysis Core at the University of Virginia School of Medicine (Charlottesville, 
VA).  Androstenedione concentration was measured by RIA, and the final concentration 
was expressed in ng/ml. 
 
 
Immunoblot analysis 
 
 Immunoblot analysis was performed in whole testes samples as described in 
Chapter 2.  Testes were probed for the following ABC transporters: Abcc1 (Abcam), 
Abcb1 (Thermo Scientific), Abcg2 (Axxora), Abcc4 (M4I-10, a gift from Dr. George 
Scheffer), and Abcc5 (M5I-10, a gift from Dr. George Scheffer).  Actin (Sigma Aldrich) 
was used as a loading control. 
 
 Liver microsomes were examined for protein expression of the following Cyps:  
Cyp2b10, Cyp3a11 and Cyp1a2 (a gift from Dr. Erin Schuetz). 
 
 
Immunohistochemistry 
 
 Whole prostate was harvested from Mrp4 WT and KO mice and immediately 
formalin fixed.  Samples were submitted to the St. Jude Veterinary Pathology Core where 
they were paraffin embedded and sectioned into 4 micron sections.  Following standard 
slide mounting procedure, samples were stained with H&E for analysis of overall 
prostate morphology.  All staining was performed using the LabVision 720 autostainer 
(Thermo Shandon). 
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Real-time PCR 
 
 Real-time PCR was performed on whole liver samples from WT and KO mice 
using 20ng of diluted cDNA with SYBR Green (Invitrogen) and 300 nM gene specific 
primers using the ABI 7900HT sequence detection system (ABI).  Primer sequences were 
designed using Primer Express (ABI).  The PCR protocol was as follows:  10 minutes 
denaturation step, 40 cycles of two-step PCR (15 seconds at 95oC and 60 seconds at 
60oC) followed by a dissociation step (15 seconds at 95oC, 15 seconds at 60oC and 15 
seconds at 95oC).  The fold difference in expression was normalized to the housekeeping 
gene Gapdh and was calculated using the ??Ct method.  The primer sequences utilized 
were as follows:  Cyp2b9 (sense, 5’- TGCTCAAGTACCCCCATGTCA-3’; antisense, 
5’- AGAGAAAGTCCAAAAGGAGA-3’), Cyp2b10 (sense, 5’- 
TCTTCCAACGTTCCCCATTG-3’; antisense, 5’- TCTTCCAACGTTCCCCATTG-3’), 
Cyp7a1 (sense, 5’- AATGCACTTGGATCCTGAAATCTAC-3’; antisense, 5’- 
TTCATCAAGGTACCGGTCGTATT-3’), Cyp7b1 (sense, 5’- 
CGGCCCTGTTCCTCCTTAC-3’; antisense, 5’- 
GATAAGGAAGCCAACCTTTTATCAAG-3’), Cyp3a11 (sense, 5’- 
CCAAACCTCTGCCATTTTTAGG-3’; antisense, 5’- 
GCACTCCATGTCGAATTTCCA-3’), Cyp3a13 (sense, 5’- 
GCTGATGATAAACTCCCAGAATTACAA-3’; antisense, 5’- 
CCAAAGAATCTCATAAAGC-3’) and Cyp1a2 (sense, 5’- 
ATCCTTTGTCCCCTTCACCAT-3’; antisense, 5’- GGGAATGTGGAAGCCATTCA-
3’). 
 
 
Microarray analysis 
 
 Analysis of liver gene expression used three mice per genotype and age group.  
Samples were quality assessed as described in chapter 3 then processed using the 
Affymetrix 3’ IVT express protocol.  Labeled targets were hybridized on the HT_MG-
430_PM plate array and processed using the Gene-Titan system.  Array signals were 
summarized using the RMA algorithm with Affymetrix Expression Console software.  
Cytochrome p450 targets were identified using Affymetrix Gene annotations while 
transcriptional targets of AR and CAR were identified using curated terms from GeneGo 
and Metacore pathways. 
 
 
Liver microsome isolation 
 
 Approximately 50-100 mg liver samples from pre-pubertal and adult mice were 
homogenized in homogenization buffer (100 mM Tris base, 100 mM KCl, 1 mM 
ethylenediaminetetraacetic acid and 20 uM butylated hydroxytoluene) using a Potter 
pestle attached to an electric drill motor.  Samples were centrifuged at 18,500 x g for 15 
minutes at 4oC, supernatant collected then spun at 106,000 x g for 60 minutes at 4oC.  
The pelleted microsomal fraction was resuspended in microsomal storage buffer (100 
mM potassium phosphate, 1 mM ethylenediaminetetraacetic acid, 1 mM dithiothreitol, 20 
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uM butylated hydroxytoluene and 20% glycerol).  Microsome protein concentration was 
determined using by the Bradford assay method. 
 
 
Testosterone metabolite analysis  
 
 Mouse liver microsomes were suspended in 10 mM phosphate buffer (pH 7.4) 
containing 10 mM MgCl2 and 2.4 mM NADPH.  Testosterone was added (200uM final 
concentration) followed by a 60 minute incubation at 37oC.  The reaction was terminated 
by the addition of an equal volume of cold methanol and precipitated proteins were 
separated by centrifugation at 13000 x g for 5 minutes at room temperature.  One hundred 
microliters of sample were injected into the HPLC system for metabolite analysis.  HPLC 
was performed using the Waters 500-717-2487 systems (Waters) and chromatographic 
separation was achieved using a reverse phase Hibar RT 250-4 pre-packed column 
(Merck).  The mobile phase was 50% methanol, 50% water (v/v) with a run time of 50 
minutes.  Data acquisition and analysis was performed using Empower 2 software.  The 
rate of formation of each metabolite is expressed at picomole/mg/min.  The following 
standards were used:  6?-hydroxytestosterone, 6?-hydroxytestosterone, 16?-
hydroxytestosterone, 16?-hydroxytestosterone, and 7?-hydroxytestosterone (Steraloids, 
Inc.) 
 
 
Liver testosterone measurement 
 
 Liver samples were harvested from pre-pubertal and adult WT and KO mice, and 
testosterone was extracted and measured as described in chapter 2. 
 
 
PROD assay 
 
 Approximately 20 ug of liver protein extract was combined with 0.2ml Buffer A 
(1.25 mM ethylenediaminetetraacetic acid, 1 mg/ml bovine serum albumin, 10 uM 
dicumerol, 4 uM 7-pentoxyresorufin, and 40 mM Tris pH 8.3).  Samples were incubated 
for 1 minute at 37oC, and the reaction was started by the addition of 25ul of 10 mM 
NADPH.  The mixture was incubated for 5 minutes at 37oC, and the reaction was stopped 
by adding .25 ml ice cold methanol.  Samples were then spun at 5900 x g at 4oC.  
Florescence was read at an excitation/emission spectra of 558/590. 
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Results 
 
 
Serum testosterone concentration is drastically reduced in pre -pubertal Mpr4 KO 
mice but is restored with age  
 
Measurement of serum testosterone concentration in pre-pubertal Mrp4 KO mice 
revealed an approximate 90% reduction when compared to Mrp4 WT animals        
(Figure 5-1A).  Interestingly, upon reaching adulthood, serum testosterone levels were 
relatively normal between the genotypes (Figure 5-1B).  Circulating androstenedione 
concentrations were similar between the genotypes at both ages (Figure 5-1C), indicating 
the adrenal gland was not affecting the observed serum testosterone concentration.  
Additionally, immunoblot analysis of adult adrenal glands revealed no major alterations 
in StAR or Pbr protein expression, suggesting the increased serum testosterone in KO a 
mouse is not a result of increased testosterone biosynthesis in the adrenal glands   
(Figure 5-2).  To confirm that circulating testosterone was significantly altered in pre-
pubertal KO animals, prostate morphology was examined as the prostate requires 
exogenous testosterone for maturation [160].  Immunohistochemical analysis showed 
impaired prostate maturation in the pre-pubertal KO mouse, exhibiting disorganized 
tubular structure and enlarged interstitial space (Figure 5-3A) as compared to its WT 
counterpart.  By adulthood, when serum testosterone levels were similar between the 
genotypes, prostate morphology was indistinguishable (Figure 5-3B), representative of a 
normal circulating testosterone concentration. 
 
 
Additional ABC transporters expressed in the testes are not unregulated in the 
Mrp4 KO mouse 
 
 As other ABC transporters are expressed in the testes and interact with steroids 
which are structurally similar to testosterone [161], we examined their expression in adult 
testes to determine if that may account for the rise in serum testosterone in KO mice.  All 
inspected transporters (Abcc1, Abcb1, Abcg2 and Abcc5) showed no increase in protein 
expression in these animals (Figure 5-4A).  Abcc2 expression was undetectable.  
Likewise, real-time PCT analysis of Slco6b1 and Slco6c1, reported androgen efflux 
transporters [162] showed no upregulation in Leydig cells (Figure 5-4B).  These findings 
suggested the rise in circulating testosterone concentration in the adult KO mouse was 
not a product of increased expression of steroid efflux transporters. 
 
 
Decreased serum testosterone in pre-pubertal Mrp4 KO mice is a result of increased 
testosterone metabolism by Cyp2b10 
 
 Microarray analysis of pre-pubertal liver samples of Mrp4 WT and KO mice 
showed increased Cyp2b10 expression in KO mice as compared to WT.  Expression 
levels returned to those seen in WT mice once the KO mice reached adulthood.  Other   
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Figure 5-1. Serum testosterone concentration is decreased in the pre -pubertal 
Mrp4 KO mouse but normalizes with age.  (A)  Serum testosterone concentration in 
pre-pubertal Mrp4 mice as measured by radioimmunoassay (WT, n = 7; KO, n = 10).    
(B)  Serum testosterone concentration in adult Mrp4 mice as measured by 
radioimmunoassay (WT, n = 10; KO, n = 15).  (C)  Serum androstenedione 
concentration in adult mice assessed by radioimmunoassay (n = 2 mice/genotype).  All 
error bars = SE. 
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Figure 5-2. Protein expression of cholesterol importers are not decreased in Mrp4
KO adrenal glands.  Expression of StAR and Pbr in Mrp4 WT and KO mouse adrenal 
glands as determined by immunoblot assay.  
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A B 
Figure 5-3. Pre-pubertal Mrp4 KO mice exhibit impaired prostate morphology 
while adult KO mice are normal.  Prostate gland morphology of (A) pre-pubertal and 
(B) adult Mrp4 mice.  (H&E, 400X magnification) 
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Figure 5-4. Alternate ABC and steroid transporters are not upregulated in Mrp4 
KO mice.  (A)  Immunoblot analysis of ABC transporters in adult testes.  ?-actin was 
used as a loading control.  (B)  mRNA expression of Slco6b1 and Slco6c1 in KO Leydig 
cells analyzed by real-time PCR, normalized to Rsp16 expression. 
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testosterone metabolizing Cyps (Cyp1a2, Cyp2b9, Cyp3a11, Cyp3a13, Cyp7a1 and 
Cyp7b1) did not exhibit the same pattern of expression as Cyp2b10 (Figure 5-5).  In 
accordance with the microarray data, real-time PCR confirmed Cyp2b10 expression was 
elevated in pre-pubertal Mrp4 KO liver microsomes but returned to a comparable level 
with the WT at an adult age (Figure 5-6A).  Upregulated liver microsome Cyp2b10 
protein expression was observed in individual KO mice versus expression in WT mice, 
Cyp2b10 expression was variable in adult animals regardless of genotype.  Protein 
expression of Cyp3a11 increased with age but was not altered between the WT and KO 
samples in either age group.  Cyp1a2 protein levels were consistent regardless of age or 
Mrp4 status (Figure 5-6B). 
 
 In addition to analyzing Cyp2b10 expression, catalytic activity was also 
examined.  Total Cyp2b activity, as assessed by pentoxyresorufin O-dealkylase (PROD) 
assay, in pre-pubertal KO samples was elevated when compared to the WT.  This was not 
observed in adult mice (Figure 5-7A).  Correspondingly, increased formation of 
hydroxylated testosterone metabolites was detected with an approximate 60% increase in 
metabolites observed in the pre-pubertal Mrp4 KO mice (Figure 5-7B).  This data is in 
accordance with the PROD results. 
  
Liver testosterone concentration was then measured to validate the results seen 
with increased Cyp2b10 expression and catalytic activity.  In accordance with the 
previous results, testosterone levels in pre-pubertal Mrp4 KO mice were substantially 
reduced when compared to the corresponding WT animals.  No difference in testosterone 
concentration was observed in adult mice (Figure 5-8). 
 
 
Elevated Cyp2b10 expression is not a result of general CAR activation 
 
 To further verify Cyp2b10 expression was determinant on testosterone 
concentration and not other regulatory factors that modulate Cyp2b10, several factors 
were assessed.  Real-time PCR analysis revealed similar AR mRNA expression in pre-
pubertal livers (Figure 5-9A); however, expression of AR target genes was largely 
downregulated in the KO mouse (Figure 5-9B).  This decreased activation is consistent 
with decreased testosterone concentration in these animals. 
 
 In vivo studies have shown that testosterone suppresses Cyp2b10, possibly by 
suppressing CAR activity [163].  Gene expression analysis of CAR target genes in pre-
pubertal mice revealed that only Cyp2b10 is strongly upregulated in Mrp4 KO mice 
(Figure 5-10) indicating the general de-repression of CAR cannot explain the increased 
Cyp2b10 upregulation in KO liver. 
 
 
Conclusions 
 
 Serum testosterone concentrations were found to be greatly reduced in the pre-
pubertal KO animal but increased to a more normalized level upon reaching adulthood.   
 61 
  
 
 
Figure 5-5. Cyp2b10 RNA expression is upregulated in pre-pubertal Mrp4 KO 
mice but decreases at an adult age.  Expression heat map of all Cyp450 genes in the 
liver.  Enlarged map shows testosterone metabolizing Cyp450s only (n = 3 mice per age 
and genotype).  Expressed as change compared to WT values.
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Figure 5-6. Both mRNA and protein expression of Cyp2b10 are elevated in pre-
pubertal Mrp4 KO mice but decrease in adulthood.  (A)  Hepatic expression of 
testosterone metabolizing enzymes in pre-pubertal and adult Mrp4 KO mice (n = 3 mice 
per age and genotype group).  Real time-PCR data is normalized to Gapdh expression 
and presented as the ratio of expression compared to WT mice.  (B)  Representative 
immunoblot analysis of Cyp2b10 and Cyp3a11 proteins in liver microsomes (n = 3 mice 
per age and genotype.)  Cyp1a2 was used as a loading control.  Mean ratios of band 
intensity from two separate experiments are graphed to the right using ImageJ software.  
All error bars = SE. 
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Figure 5-7. Testosterone metabolism is increased in pre-pubertal Mrp4 KO 
animals.  (A)  Cyp2b enzyme activity in liver microsomes determined by PROD assay.  
(B)  Measurement of hydroxylated testosterone metabolites from liver microsomes using 
HPLC analysis (n = 3 mice per age and genotype).  Cyp450s in parenthesis represent the 
major Cyp responsible for the corresponding metabolite.  All error bars = SE.
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Figure 5-8. Liver testosterone concentration is decreased in pre-pubertal 
KO mice compared to WT.  Total testosterone concentration in pre-pubertal and 
adult Mrp4 mouse liver as measured by radioimmunoassay (n = 4 mice per age and 
genotype).  Error bars = SE.  
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Figure 5-9. Androgen receptor target genes are downregulated in pre-pubertal 
Mrp4 KO mice.  (A)  Hepatic androgen receptor mRNA expression assessed by real-time 
PCR normalized to Gapdh expression.  (B)  Heat map representing the expression of 
androgen receptor targets in pre-pubertal Mrp4 KO mice in relation to WT expression 
levels. 
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Figure 5-10. A general downregulation of Car target gene expression is not 
observed in pre-pubertal Mrp4 KO mice.  Heat map representing hepatic gene 
expression of Car target genes in pre-pubertal KO mice in relation to WT gene 
expression. 
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Confirmation of these effects was seen upon examination of prostate morphology, an 
organ which requires circulating testosterone for maturation.  Pre-pubertal KO prostate 
presented with a disorganized structure and excess interstitial space while the adult KO 
prostate was identical to the WT.  Circulating androstenedione concentrations were not 
altered between the genotypes, and upregulation of other ABC transporters present in the 
testes was not observed. 
 
 Increased Cyp2b10 expression and activity was confirmed in the pre-pubertal KO 
mice.  No other testosterone metabolizing Cyp examined exhibited this increase.  Upon  
reaching an adult age, Cyp2b10 in KO mice showed a considerable decrease in both 
expression and activity.  This metabolizing effect was also confirmed by liver 
testosterone levels which showed the same pattern as serum testosterone.  Finally, the 
change in Cyp2b10 expression was not a result of CAR activation as it was the only 
target gene upregulated in our analysis, confirming its expression levels are dependent on 
testosterone concentration in this system.  
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CHAPTER 6.     DISCUSSION 
 
 
Mrp4 Is Localized to Leydig Cells 
 
 Prior to our initial experiments, Mrp4 was well reported to have testicular 
expression; however, its cellular localization and specific role had yet to be determined 
[136, 137].  Through the use of immunoblot and immunohistochemical techniques, Mrp4 
was discovered to be specifically localized to the Leydig cell compartment.  Leydig cells 
are responsible for the synthesis and release of the primary male sex hormone 
testosterone [57] which is vital for the maintenance of spermatogenesis [164]. 
 
 While it has been shown that ABC transporters expressed in the testes play their 
expected cytoprotective role in effluxing toxic compounds as indicated by the protective 
role of Mrp1 at the blood-testes barrier [140], data has also been presented which 
highlights the importance of these transporters in regulating testosterone levels.  In 
addition to the previously discussed testosterone deficiency observed in Abcc1 KO 
animals, ABCA1 KO mice also exhibit reduced intratesticular testosterone levels.  
Primarily expressed in Sertoli cells, the absence of ABCA1 results in abnormal lipid 
accumulation in Sertoli cells and depletion of lipid droplets from Leydig cells, producing 
partially compromised  Leydig cell function [165].  However, no evidence had been 
presented directly linking the loss of Mrp4 to testosterone deficiency.  Interestingly, 
substrates of Mrp4 had been implicated in negatively impacting androgen response.  In 
vivo analysis of chronic methotrexate treatment in rats showed decreased testosterone as 
compared to untreated controls.  Two enzymes involved in the steroid biosynthesis 
pathway, 17?HSD and 3?HSD both showed decreased activity [166].  Likewise, aspirin, 
both a substrate and inhibitor of Mrp4 [167, 168] has been reported to impact 
steroidogenesis.  Acute aspirin administration in humans showed impaired 
steroidogenesis, a phenomenon most likely due to aspirin’s interference with LH-hCG 
action on the plasma membrane of Leydig cells [169].  Aspirin dosing in rodents resulted 
in decreased spermatid numbers, producing a morphology consistent with impaired germ 
cell maturation [170, 171].  With initial data confirming the localization of Mrp4 to 
Leydig cells, coupled with literature evidence supporting that inhibition of Mrp4 impairs 
steroidogenesis and spermatogenesis, it was hypothesized that Mrp4 deficient mice may 
possess an inherent defect in testosterone production. 
 
 
Mrp4 KO Mice Have an Inherent Deficiency in Testicular Testosterone 
Concentration 
 
 Intratesticular testosterone measurements revealed severely impaired levels in 
Mrp4 KO animals both prior to puberty and at an adult age.  To confirm these results, a 
series of testosterone dependent parameters were observed.  Pre-pubertal Mrp4 KO mice 
possessed half the number of primary spermatids within the seminiferous tubules than did 
the WT mouse, consistent with low availability of testosterone [143, 172].  Germ cell 
maturation is controlled by a balance of cell proliferation and apoptosis [144, 153], and 
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pre-pubertal KO mice exhibited decreased germ cell proliferation and increased 
apoptosis.  These findings are consistent with previous studies that illustrate gonadotropin 
deprivation and/or testosterone withdrawal results in increased apoptosis at multiple 
stages of germ cell development [173, 174].  However, despite the continued reduction in 
testicular testosterone concentration in adult Mrp4 KO mice, proliferation and apoptosis 
measurements were comparable to those seen in Mrp4 WT animals.  We sought an 
explanation for the restoration of testicular morphology in adult KO mice despite their 
sustained testosterone reduction. 
 
 It is well documented that testosterone is essential for spermatogenesis, although 
the absolute levels required are still debatable.  In rodents and primates, intratesticular 
testosterone levels are elevated approximately 100 fold over serum concentrations by 
virtue of its localized production.  These concentrations are in excess if what is required 
to saturate the AR [175].  Experimental reduction of testicular testosterone levels in rats 
led to an abolition in sperm production when the concentration was less than 20% of that 
of the controls [152].  This proportionate reduction was observed in the pre-pubertal and 
adult Mrp4 KO mice, but only the younger animals exhibited signs of impaired 
spermatogenesis.  Critical analysis of testosterone concentration in KO mice revealed a 
four-fold increase in testosterone levels as the mice reached adulthood.  While the 
concentration remains decreased in adult KO mice, it is conceivable that the four fold 
increase generates enough testicular testosterone to saturate the AR in the testes, thus 
allowing normal progression of spermatogenesis in these animals. 
 
 In conclusion, our initial studies revealed the localization of Mrp4 to the Leydig 
cells.  Additionally, it was observed the loss of Mrp4 resulted in decreased intratesticular 
testosterone in these animals, but this deficiency negatively impacted mice before 
puberty.  As adult mice possessed normal testicular morphology and were reproductively 
comparable to the WT animals with respect to litter size, it appeared the loss of Mrp4 did 
not contribute to an overall detrimental phenotype in the adult KO testes. 
 
 
Cyclic AMP Is the Regulatory Factor Controlling Decreased Testosterone Synthesis 
in the Mrp4 KO Mouse 
 
 The data presented in this section provided the first evidence that the absence of 
Mrp4 in the testes resulted in an inherent defect in Leydig cell testosterone biosynthesis.  
While prior studies had demonstrated the loss of a testicular transporter resulted in 
impaired intratesticular testosterone concentration, the mechanism underlying the 
decrease had failed to be fully characterized or was not dependent on the transporter’s 
expression in the Leydig cells.  We provided evidence that the testicular testosterone 
deficiency characterized in the Mrp4 KO mouse was a product of decreased intracellular 
cAMP concentration, leading to a downstream cascade of impaired biosynthetic 
processes, including CREB phosphorylation and diminished testosterone biosynthetic 
gene expression.   
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Proper regulation of cAMP is critical for the maintenance of testosterone biosynthesis, as 
it is a primary regulator of many steps in testosterone formation.  Luteinizing hormone 
receptor mRNA expression requires basal cAMP expression [99].  However, long-term 
incubation of the MA-10 Leydig cell line with a cAMP derivative resulted in decreased 
LHR mRNA [100], presumably due to increased receptor degradation by receptor-
mediated endocytosis.  While this may initially appear to be inconsistent with our data 
showing decreased cAMP concentration, acute LH stimulation of Leydig cells generated 
an increase in intracellular cAMP levels in the Mrp4 KO.  It can be surmised that this 
initial accumulation of cAMP potentially triggers receptor internalization, resulting in 
decreased Lhr expression observed in Mrp4 KO Leydig cells. 
 
 Cyclic AMP also modulates a variety of aspects of testosterone biosynthesis 
through its binding and activation of CREB.  CREB mediated gene transcription is 
achieved by activation of PKA and subsequent phosphorylation of CREB.  In turn, CREB 
binds the conserved cAMP response element TGACGTCA typically found in the 
promoter of many cAMP responsive genes [102].  Multiple genes in the testosterone 
biosynthesis pathway contain CREB binding sites in their promoter regions.  The 
activation of the StAR protein, the rate limiting step in steroid biosynthesis, is dependent 
on cAMP.  The StAR promoter does not contain the typical CRE binding motif but 
instead contains a cAMP responsive region that has functional elements for other 
transcriptional activities [103].  Despite the absence of a consensus CRE site, studies 
have shown the classical cAMP-PKA signaling cascade activates CREB and upregulates 
the transcription of the StAR gene [104, 105].  StAR expression is vital for steroid 
biosynthesis as shown in cell culture context as well as with a StAR KO mouse model.  
Mice lacking StAR exhibited Leydig cell hyperplasia and a reduced capacity for 
spermatogenesis [44], indicating these animals possess insufficient androgen production 
to maintain optimal spermatogenesis. 
 
 Our results in Mrp4 KO mice reveal both a decrease in cAMP concentration as 
well as lowered StAR mRNA and protein expression.  Although the phosphorylation 
status of StAR has yet to be determined, based on prior reports, the Mrp4 KO animal 
could potentially possess a deficiency in StAR phosphorylation due to lowered cAMP 
concentration and possible decreased PKA activation.  In addition to CREB binding, 
cAMP responsiveness of the StAR promoter is also regulated by SF-1 [176] which has 
been identified as essential to both basal and hormone induced cAMP regulation of StAR 
[177, 178].  Microarray analysis of whole testes revealed a slight decrease in SF-1 
expression in KO animals (data not shown) thereby adding another factor that could 
account for the decreased StAR expression observed in these animals. 
 
 The concurrent cholesterol importer, Pbr, is not reported to be under CREB 
activation; however, a cAMP–inducible element that regulates Pbr structure and function 
is present as inhibition of PKA results in reduced steroid formation in MA-10 cells [108].  
Functionally, Pbr exists in a complex with other proteins including VDAC, ANT, pk10, 
PRAX-1 and PAP7 [179].  We observed no downregulation of either Pbr or Vdac protein 
expression in Mrp4 KO testes in spite of reduced cAMP concentration, indicating the Pbr 
complex may be regulated by other crucial factors.  It has been suggested that Pbr may 
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play a role in controlling the import of StAR into the mitochondria as Leydig cells with 
knocked down Pbr expression generated low formation of mature StAR protein in 
response to hormone stimulation, correlating with an absence of steroid formation [95].  
For our studies it may be inferred, in the presence of impaired cAMP concentration and 
StAR expression, the equivalent expression of Pbr in Mrp4 WT and KO testes is 
responsible for the observed testicular testosterone, albeit minimal, concentration in these 
mice. 
 
 For CREB induced gene expression, the duration of Ser133 phosphorylation has 
been shown to determine the efficacy of expression.  In a subtype of striatal neurons, 
stimulation with dopamine, a cAMP activating neurotransmitter, involves Ser133 
phosphorylation that is maintained 30 minutes after stimulation.  In other subtypes of 
striatal neurons, Ser133 phosphorylation is more transient as dephosphorylation occurs 
within 15 minutes of the stimulus.  In neurons where phosphorylation is sustained, CREB 
target genes are induced whereas unsustained phosphorylation does not promote gene 
induction [111].  These results bolster our data that exhibits minimal Ser133 
phosphorylation in Mrp4 KO Leydig cells stimulated with LH.  After 30 minutes 
exposure to hormonal stimulation, the phosphorylation state of these cells was barely 
altered above the basal level.  As illustrated with neuronal cells, this non-existent Ser133 
phosphorylation in Mrp4 KO Leydig cells produced a host of inactivated downstream 
gene targets.  
 
 The decrease in cAMP concentration measured in Mrp4 KO Leydig cells was 
initially a puzzling finding as it was anticipated cAMP levels would be elevated as it is a 
well-established substrate for Mrp4.  More detailed analysis revealed, however, that acute 
inhibition of Mrp4 when stimulated with LH resulted in increased intracellular cAMP 
accumulation in the WT cells.  As the activation of adenylyl cyclase and the formation of 
cAMP occurs within seconds of receptor activation [180], it can be postulated that the 
decreased cAMP concentration in KO Leydig cells is not a result of abated formation but 
instead of increased degradation by PDEs.  Phosphodiesterases including PDE4A [181], 
PDE5A [182], PDE8A [148] and PDE8B [183] have been localized to the testes.  Both 
PDE8A and PDE8B are highly expressed in Leydig cells, and their inhibition increases 
PKA-dependent phosphorylation and protein expression of components of 
steroidogenesis [183].  The same experiments have also shown additional inhibition of 
PDE4 synergize potentiated steroid production, demonstrating these PDEs function to 
maintain low cAMP levels thereby suppressing steroidogenesis.  While PDE status has 
yet to be clarified in our experiments, based on our data, increased PDE concentrations 
may be responsible for the long-term depression of cAMP concentration detected in 
Mrp4 KO Leydig cells.  Our future studies aim to examine this more in depth. 
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Increased Cyp2b10 Expression and Activity Results in Decreased Serum 
Testosterone in Pre-pubertal Mrp4 KO Mice 
 
 Our results from these sets of experiments highlight the important relationship 
between testosterone concentration and Cyp2b10 expression.  Initial findings of 
decreased serum testosterone concentration in pre-pubertal Mrp4 KO mice but 
normalized adult levels were originally a perplexing result.  Although testicular 
testosterone biosynthesis was reduced regardless of age (refer to chapters 2 and 4), it was 
not anticipated that its release from the testes impacted circulating concentrations, as 
testosterone is not a substrate for Mrp4 [54].  While the common route for testosterone 
release is generally accepted to be passive diffusion [64], androgen efflux proteins have 
been characterized.  The rat gonad specific transporters Slco6a1 and Slco6b1 transport 
DHEAS [162] while Abcg2 effluxes steroids including estradiol, progesterone, and 
testosterone [148].  Similarly, ABC transporters ABCG1 and ABCG5 have been 
implicated in cholesterol transport [184, 185].  Our samples were evaluated for 
expression of some of these transporters to determine if increased expression in adult 
Mrp4 KO mice could be responsible for elevated serum testosterone concentration.  As 
our results revealed that none of the transporters showed upregulation in the KO, it was 
concluded that increased serum testosterone was not a result of potentially increased 
transport. 
 
 Based on published reports stating testosterone concentration and Cyp2b10 
expression have a negative correlation, we proposed decreased serum testosterone in pre-
pubertal KO mice was a result of increased Cyp2b10 expression and catalytic activity.  
Results from microarray analysis and real-time PCR showed increased Cyp2b10 
expression in KO mice.  Likewise, elevated Cyp2b10 protein expression was observed in 
pre-pubertal Mrp4 KO liver microsomes.   Although Cyp3a11 is an important 
testosterone metabolizing enzymes, no change in expression was ever observed in our 
samples. Unlike with Cyp2b10, there is no current evidence that Cyp3a11 expression 
depends on testosterone concentration.  The adult samples did show the expected increase 
in expression regardless of genotype [113, 186].  Consistent with the expression data, 
Cyp2b10 catalytic activity was elevated in the pre-pubertal KO mice.  Increased 16?- and 
16?-hydroxylated metabolites were consistent with elevated Cyp2b10 activity, as they 
are primarily metabolized by the enzyme [124, 125]. 
 
 The actions of testosterone and other androgens are mediated through the AR, a 
ligand dependent transcription factor.  Upon entry into the androgen target cell, 
testosterone either binds directly to the AR or binds following its conversion to DHT.  
Following a series of conformational changes, activation or repression of downstream 
target genes occurs [187].  Our microarray analysis of pre-pubertal Mrp4 KO liver 
showed AR target genes were largely downregulated in comparison to WT, compatible 
with reduced liver testosterone concentrations.  Based on these results, it is conceivable 
to speculate DHT concentrations were similarly reduced in these animals although levels 
were not measured. 
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 Studies have shown endogenous androgens repress the nuclear orphan receptor 
CAR, of which Cyp2b10 is a target gene [163].  We aimed to test if general de-repression 
of CAR target genes was secondary to reduced hepatic testosterone in pre-pubertal KO 
mice.  The gene expression pattern was similar between the genotypes with the exception 
of strongly induced Cyp2b10 expression in the KO liver.  Therefore, general de-
repression of CAR could not explain the increased hepatic Cyp2b10 in pre-pubertal KO 
mice. 
 
 In conclusion, these studies show reduced systemic testosterone concentration in 
pre-pubertal Mrp4 KO mice is a result of increased metabolism by Cyp2b10 and 
decreased testicular testosterone production  However, in adult mice, circulating 
testosterone concentration returns to near normal levels despite a sustained reduction in 
testicular testosterone due to alleviated testosterone metabolism. 
 
 
Genetic Variants Highlight the Importance of Proper Functioning Mrp4 
 
 The data shown here provides the first evidence that the absence of Mrp4 in a KO 
mouse model results in the downregulation of a steroid biosynthetic pathway.  However, 
several human mutations of MRP4 have been identified, with some creating detrimental 
effects due to lack normal MRP4 function.  Studies conducted in Xenopus laevis oocytes 
expressing the human MRP4 missense mutation V776I revealed a decreased ability of 
these oocytes to transport 6-mercaptopurine (6MP).  In conjunction with decreased 
transport, the V776I mutation also exhibited reduced protein expression as well as plasma 
membrane surface expression [188].  Similar types of studies performed in HEK293 cells 
also reinforced the importance of properly functioning MRP4.  For this report, an 
ethnically diverse population (270 healthy individuals) was used to obtain potential 
MRP4 variants in the general population.  A total of 98 variants were identified, and ten 
were chosen for analysis based on a frequency of ≥5% in the population studied.  While 
none of the variants were observed to be completely deleterious, both G187W and 
G487E, both evolutionarily conserved, exhibited significantly reduced ability to transport 
both azathioprine (AZA) and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA).  The 
P78A and P403L variants, also evolutionarily conserved, showed reduced function when 
transporting AZT [189].  A single nucleotide polymorphism (rs3765534) found in human 
MRP4, common in approximately 18% of the Japanese population, renders cells more 
susceptible to 6MP toxicity than cells with WT MRP4.  This variant allele showed 
similar protein expression when transfected into HEK293 cells but strongly reduced cell 
surface expression, a factor that contributes to increased intracellular thioguanine 
nucleotide concentration [45].  Based on these and other data, it can be hypothesized that 
naturally occurring MRP4 variants, in addition to contributing to chemotherapeutic 
toxicity, may also play a role in reducing testosterone concentration in human males.  
Although this has yet to be examined, it merits investigation in order to fully understand 
the crucial role of MRP4 in the testes. 
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Future Directions 
 
 The complete set of studies presented here show Mrp4 is a crucial factor in 
regulating normal testosterone biosynthesis.  We anticipate future studies based on this 
work will highlight the importance of Mrp4 expression in Leydig cells as it relates to 
chemotherapeutic drug induced male sterility.  Multiple cancer chemotherapeutic drugs 
produce detrimental reproductive effects secondary to impaired testosterone production.  
Chronic administration of azathioprine and methotrexate have been lined to sperm 
toxicity [190] and decreased testosterone concentration [166], respectively, in rodents.  6-
mercaptopurine, a routinely administered drug in both childhood [191] and adult [192] 
acute lymphoblastic leukemia, is reported as a carcinogen [193] that negatively impacts 
reproductive capabilities [194].  These studies all conclude the adverse reproductive 
effects are a result of decreased testosterone concentration.  We anticipate Mrp4 protects 
Leydig cells from chemotherapeutic toxicity caused from these agents through its ability 
to both efflux these substrates as well as maintain normal testosterone biosynthesis. 
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